
<html lang="en"     class="pb-page"  data-request-id="39ed8eea-7f34-42a0-8804-3981149843a4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm8010993;issue:issue:10.1021/jmcmar.2009.52.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Dual Inhibitors of Phosphodiesterase-4 and Serotonin Reuptake" /></meta><meta name="dc.Creator" content="John R.  Cashman" /></meta><meta name="dc.Creator" content="Troy  Voelker" /></meta><meta name="dc.Creator" content="Han-Ting  Zhang" /></meta><meta name="dc.Creator" content="James M.  O’Donnell" /></meta><meta name="dc.Description" content="A new class of multitarget compounds was synthesized by linking a novel selective serotonin reuptake inhibitor (SSRI) to a PDE4 inhibitor. The new dual PDE4 inhibitor/SSRI showed antidepressant-lik..." /></meta><meta name="Description" content="A new class of multitarget compounds was synthesized by linking a novel selective serotonin reuptake inhibitor (SSRI) to a PDE4 inhibitor. The new dual PDE4 inhibitor/SSRI showed antidepressant-lik..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 3, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8010993" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8010993" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8010993" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8010993" /></link>
        
    
    

<title>Dual Inhibitors of Phosphodiesterase-4 and Serotonin Reuptake | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8010993" /></meta><meta property="og:title" content="Dual Inhibitors of Phosphodiesterase-4 and Serotonin Reuptake" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0007.jpeg" /></meta><meta property="og:description" content=" A new class of multitarget compounds was synthesized by linking a novel selective serotonin reuptake inhibitor (SSRI) to a PDE4 inhibitor. The new dual PDE4 inhibitor/SSRI showed antidepressant-like activity in the forced swim test in mice The SSRIs 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine (14) and 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine (15) were both individually linked to the PDE4 inhibitor 4-(3,4-dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one (19), via a five-carbon chain. The dual PDE4 inhibitor/SSRI 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl]-4,5,8,8a-tetrahydro-2H-phthalazin-1-one (21) showed potent and selective serotonin reuptake inhibition (IC50 value of 127 nM). The dual PDE4 inhibitor/SSRI 21 also inhibited PDE4D3 with a Ki value of 2.0 nM. The dual PDE4 inhibitor/SSRI was significantly more effective than the individual SSRI alone or fluoxetine in the forced swim test at standard doses. On a molar basis, the antidepressant-like effect of the dual PDE4 inhibitor/SSRI 21 showed a 129-fold increase in in vivo efficacy compared to fluoxetine." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8010993"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8010993">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8010993&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8010993&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8010993&amp;href=/doi/10.1021/jm8010993" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1530-1539</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8015188" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm801532e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dual Inhibitors of Phosphodiesterase-4 and Serotonin Reuptake</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+R.++Cashman">John R. Cashman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Troy++Voelker">Troy Voelker</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Han-Ting++Zhang">Han-Ting Zhang</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+M.++O%E2%80%99Donnell">James M. O’Donnell</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, California 92121, West Virginia University Health Sciences Center, Morgantown, West Virginia 26505</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 858-458-9305. Fax: 858-458-9311. E-mail: <a href="/cdn-cgi/l/email-protection#99f3faf8eaf1f4f8f7d9f1fbebf0b7f6ebfe"><span class="__cf_email__" data-cfemail="86ece5e7f5eeebe7e8c6eee4f4efa8e9f4e1">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Human BioMolecular Research Institute.</div><div class="corresp-fn" id="afn2">‡West Virginia University Health Sciences Center.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8010993&amp;href=/doi/10.1021%2Fjm8010993" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1530–1539</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 3, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 September 2008</li><li><span class="item_label"><b>Published</b> online</span>3 March 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8010993" title="DOI URL">https://doi.org/10.1021/jm8010993</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1530%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BR.%2BCashman%252C%2BTroy%2BVoelker%252C%2BHan-Ting%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D6%26contentID%3Djm8010993%26title%3DDual%2BInhibitors%2Bof%2BPhosphodiesterase-4%2Band%2BSerotonin%2BReuptake%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1539%26publicationDate%3DMarch%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8010993"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2050</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8010993" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dual Inhibitors of Phosphodiesterase-4 and Serotonin Reuptake&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;R. Cashman&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;Voelker&quot;},{&quot;first_name&quot;:&quot;Han-Ting&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;M. O’Donnell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;1530-1539&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8010993&quot;},&quot;abstract&quot;:&quot;A new class of multitarget compounds was synthesized by linking a novel selective serotonin reuptake inhibitor (SSRI) to a PDE4 inhibitor. The new dual PDE4 inhibitor/SSRI showed antidepressant-like activity in the forced swim test in mice The SSRIs 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine (14) and 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine (15) were both individually linked to the PDE4 inhibitor 4-(3,4-dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one (19), via a five-carbon chain. The dual PDE4 inhibitor/SSRI 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl]-4,5,8,8a-tetrahydro-2H-phthalazin-1-one (21) showed potent and selective serotonin reuptake inhibition (IC50 value of 127 nM). The dual PDE4 inhibitor/SSRI 21 also inhibited PDE4D3 with a Ki value of 2.0 nM. The dual PDE4 inhibitor/SSRI was significantly more effective than the individual SSRI alone or fluoxetine in the forced swim test at&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8010993&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8010993" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8010993&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8010993" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8010993&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8010993" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8010993&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8010993&amp;href=/doi/10.1021/jm8010993" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8010993" /></input><a href="/doi/pdf/10.1021/jm8010993" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (150 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8010993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8010993%26sid%3Dliteratum%253Aachs%26pmid%3D19256502%26genre%3Darticle%26aulast%3DCashman%26date%3D2009%26atitle%3DDual%2BInhibitors%2Bof%2BPhosphodiesterase-4%2Band%2BSerotonin%2BReuptake%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D6%26spage%3D1530%26epage%3D1539%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A new class of multitarget compounds was synthesized by linking a novel selective serotonin reuptake inhibitor (SSRI) to a PDE4 inhibitor. The new dual PDE4 inhibitor/SSRI showed antidepressant-like activity in the forced swim test in mice The SSRIs 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine (<b>14</b>) and 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine (<b>15</b>) were both individually linked to the PDE4 inhibitor 4-(3,4-dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>19</b>), via a five-carbon chain. The dual PDE4 inhibitor/SSRI 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl]-4,5,8,8a-tetrahydro-2H-phthalazin-1-one (<b>21</b>) showed potent and selective serotonin reuptake inhibition (IC<sub>50</sub> value of 127 nM). The dual PDE4 inhibitor/SSRI <b>21</b> also inhibited PDE4D3 with a <i>K</i><sub>i</sub> value of 2.0 nM. The dual PDE4 inhibitor/SSRI was significantly more effective than the individual SSRI alone or fluoxetine in the forced swim test at standard doses. On a molar basis, the antidepressant-like effect of the dual PDE4 inhibitor/SSRI <b>21</b> showed a 129-fold increase in in vivo efficacy compared to fluoxetine.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The neurodegeneration hypothesis of depression proposes that depression may be caused by maladaption of immune system and monoaminergic function.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Chronic antidepressant treatment up-regulates hippocampal neurogenesis and could thereby block or reverse cellular atrophy. Antidepressants imipramine (C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>) and amitriptyline (C<sub>20</sub>H<sub>23</sub>N) inhibit the uptake of serotonin (5-HT) and norepinephrine (NE) in vitro and in vivo. On the basis of clinical observations, inhibition of the reuptake of either of these monoamines is responsible in part for the mood-elevating action of these compounds.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Overall, the literature suggests that 5-HT may be involved in depression and elevation of 5-HT by reuptake inhibition could be clinically useful. Reuptake agents such as fluoxetine (C<sub>17</sub>H<sub>18</sub>F<sub>3</sub>NO), sertraline (C<sub>17</sub>H<sub>17</sub>Cl<sub>2</sub>N), citalopram (C<sub>20</sub>H<sub>21</sub>FN<sub>2</sub>O), and fluvoxamine (C<sub>15</sub>H<sub>21</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>) are relatively selective serotonin reuptake inhibitors (SSRIs<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: SSRI, selective serotonin reuptake inhibitor; FST, forced-swim test; PDE, phosphodiesterase; cAMP, cyclic adenosine monophosphate; ICR mice, inbred Charles River mice; 5-HT, 5-hydroxytryptamine; 5-HIAA, 5-hydroxy indole acetic acid; DA, dopamine; NE, norepinephrine; hSERT, human serotonin transporter; hNET, human norepinephrine transporter; hDAT, human dopamine transporter; DRL, differential-reinforcement-of-low-rate; ANOVA, analysis of variance; Veh, vehicle.</p></div> ) and selectively elevate 5-HT in vitro and in the brain of animals by inhibiting the human serotonin transporter (hSERT).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">SSRIs do not have marked efficacy in animal models of depression such as the forced swim test (FST) and SSRI antidepressants may require 1−4 weeks of administration to observe behavioral improvement involving longer-term adaptive changes in receptor sensitivity.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Animals treated repeatedly with SSRIs such as paroxetine (C<sub>19</sub>H<sub>20</sub>FNO<sub>3</sub>) down-regulate the SERT.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The extent of 5-HT reuptake inhibition after repeated treatment is greater than that observed after acute drug treatment.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This results in progressive increase in extracellular 5-HT and stimulation of postsynaptic receptors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> SSRIs are extensively metabolized, and metabolites are found in the liver, lung, and brain. Metabolism of antidepressants may play a significant role in overall efficacy because generally, the secondary amines (i.e., desmethyl metabolites) are more potent inhibitors of the uptake of NE than of 5-HT.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, this is not the case with fluoxetine because the main metabolite (i.e., nor-fluoxetine, C<sub>16</sub>H<sub>15</sub>F<sub>3</sub>NO) was equally as selective a 5-HT reuptake inhibitor as its parent.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> With acute treatment, SSRIs will increase 5-HT receptor-mediated cyclic adenosine monophosphate (cAMP) signaling.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Upon repeated treatment with SSRIs, this effect will be blunted (i.e., some tolerance development) because phosphodiesterases (PDEs) are up-regulated and cAMP hydrolysis is increased.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Cellular cAMP concentrations are determined by synthesis (adenylyl cyclases) and hydrolysis (cAMP PDEs). PDEs comprise a diverse group of enzymes important as regulators of signal transduction<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> coded by distinct genes, (e.g., <i>PDE4A</i>, <i>PDE4B</i>, <i>PDE4C</i>, and <i>PDE4D</i>, referred to as “subtypes”) and their selective inhibitors as “subtype-selective” inhibitors. PDE4 enzymes are particularly important in neuropsychopharmacology<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> because PDE4 hydrolyzes cAMP formed by stimulation of β adrenergic receptor-linked adenylyl cyclase in rat cerebral cortical slices.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Rolipram (C<sub>16</sub>H<sub>21</sub>NO<sub>3</sub>), a selective PDE4 inhibitor, has antidepressant activity and produces memory-enhancing effects.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Increased cAMP increases the expression of a number of PDE4 variants in neurons. Thus, in the case of SSRIs, the adaptation of PDE4 that occurs in response to repeated treatment with SSRIs is homeostatic and in opposition to the acute effects of the drugs.</div><div class="NLM_p">Selective inhibitors of PDE4 (i.e., rolipram) produce antidepressant-like effects in a number of preclinical tests sensitive to antidepressants. They antagonize the behavioral and physiological effects of reserpine (C<sub>33</sub>H<sub>40</sub>N<sub>2</sub>O<sub>9</sub>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> decrease the time of immobility in the FST in rats and mice,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and decrease response rate and increase reinforcement rate of rats under a differential-reinforcement-of-low-rate (DRL) schedule<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and support the conclusion that PDE4 inhibitors have antidepressant activity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">If SSRIs produce their effects in part via activation of cAMP signaling, then loss of activity of the PDE4 subtype involved would enhance their ability to increase cAMP and alter subsequent pharmacology. Thus, one adaptation of PDE4 that occurs in response to repeated treatment with SSRIs increases 5-HT receptor-mediated cAMP signaling. With repeated treatment, this effect will be blunted as tolerance develops because PDE4 is up-regulated and cAMP hydrolysis is increased. When animals are repeatedly treated with SSRIs, PDE4 is up-regulated.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This may be a consequence of 5-HT receptor-mediated cAMP signaling. Increased cAMP augments the expression of a number of PDE4 variants in neurons.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p last">Compared to imipramine-treated rats, a combination of rolipram and imipramine showed that chronic coadministration of a PDE4 inhibitor with an antidepressant may be more effective for depression therapy and suggest that elevation of the cAMP signal transduction pathway is involved in the antidepressive effects.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Likewise, acute treatment with fluoxetine to elevate synaptic 5-HT but not dopamine (DA) significantly enhanced rolipram binding and accumulation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Dual PDE4 inhibitor/SSRIs offer advantages beyond simple additive effects of individual agents. One hypothesis is that dual PDE4 inhibitors/SSRIs block the effect of the up-regulation of PDE4 so that the overall increase in 5-HT-mediated cAMP signaling is preserved with repeated treatment. Herein, we describe an SSRI that was chemically linked to a PDE4 inhibitor. The dual PDE4 inhibitor/SSRI was examined in vitro and in vivo for pharmacological activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The chemical synthesis of the dual inhibitors consisted of coupling an SSRI (i.e., a 2,5-disubstituted tetrahydrofuran) with a known PDE4 inhibitor (i.e., a phthalazinone) via a five-carbon linker to afford the target compound. The SSRI portion of the dual inhibitor was obtained as follows. The requisite aldehyde (i.e., <b>4</b> (3-(5′-fluoro-2′-methoxyphenyl)propanal) and <b>7</b> (4-(5′-fluoro-2′-methoxyphenyl)butyraldehyde), synthesized by standard chemistry (as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), was combined with butenyl magnesium bromide to afford the alcohols 7-(5′-fluoro-2′-methoxyphenyl)hept-1-en-5-ol (<b>8</b>) and 8-(5′-fluoro-2′-methoxyphenyl)oct-1-en-5-ol (<b>9</b>), respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Cyclization of <b>8</b> and <b>9</b> in the presence of NBS afforded the 2,5-disubstituted tetrahydrofurans 2-(bromomethyl)-5-(2′-methoxy-5′-fluorophenethyl)tetrahydrafuran (<b>10</b>) and 2-(bromomethyl)-5-(3′-(2′′-methoxy-5′′-fluorophenyl)-1′-propyl)tetrahydrofuran (<b>11</b>), respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Treatment of <b>10</b> or <b>11</b> with KCN resulted in the cyano compounds 2-cyanomethyl-5-(5′-fluoro-2-methoxyphenethyl)tetrahydrofuran (<b>12</b>) and 2-cyanomethyl-5-(3′-(2′′-methoxy-5′′-fluorophenyl)-1′-propyl)tetrahydrafuran (<b>13</b>), respectively, that were hydrogenated with H<sub>2</sub> in the presence of Raney nickel and ammonia to afford 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine (<b>14</b>) and 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine (<b>15</b>), respectively. The SSRIs <b>14</b> and <b>15</b> were used to couple with the PDE4 inhibitor portion of the molecule to afford the dual PDE4/SSRI.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0002.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) EtOC(O)CH-PPH<sub>3</sub>, DCM; (b) H<sub>2</sub>, Pd/C; (c) DiBAL, toluene; (d) [2-(1,3-dioxolan-2-yl)ethyl]triphenylphosphonium bromide; (e) acetone, H<sub>2</sub>SO<sub>4</sub>.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0003.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1-Butenylmagnesium bromide; (b) NBS, DCM; (c) KCN, NaI, DMSO; (d) Raney Ni, H<sub>2</sub>, 1 M NH<sub>3</sub> in MeOH.</p></p></figure><div class="NLM_p">The PDE4 inhibitor portion of the dual inhibitor was synthesized by a previously described route<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Because it was known that the PDE4 inhibitor 4-(3,4-dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>19</b>) possessed increased inhibitory potency upon <i>N</i>-alkylation, we hypothesized that a more potent PDE4 inhibitor could arise from linking the SSRI and PDE4 compounds via <i>N</i>-alkylation. The final target compounds 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl]-4,5,8,8a-tetrahydro-2H-phthalazin-1-one (<b>21</b>) and 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>22</b>) were prepared in a two step sequence involving: (1) attachment of a five-carbon linker by treating the phthalazinone <b>19</b> with NaH and 1,5-dibromopentane to afford 2-(5-bromo-pentyl)-4-(3,4-dimethoxy-phenyl-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>20</b>) and (2) linking <b>20</b> to <b>14</b> and <b>15</b> with the aid of CsOH (to diminish formation of the tertiary amine) to afford <b>21</b> and <b>22</b>, respectively (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The <i>N</i>-methyl derivative of <b>14</b> was synthesized in a two-step sequence starting with protection with ethylchloroformate in the presence of base to from <b>23</b> and then reduction of <b>23</b> to <b>24</b> with lithium aluminum hydride in the presence of THF (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0004.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Mg turlings, THF, reflux; (b) <i>cis</i>-1,2,3,6-tetrahydrophthalic anhydride, THF; (c) H<sub>2</sub>NNH<sub>2</sub>, EtOH, reflux; (d) 1,5-dibromopentane, NaH, DMF.</p></p></figure><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0005.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CsOH·H<sub>2</sub>O, 4 Å sieves, <b>14</b> or <b>15</b>, DMF.</p></p></figure><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0006.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ethylchloroformate, K<sub>2</sub>CO<sub>3</sub>, THF; (b) LAH, THF.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biology</h3><div class="NLM_p">Inhibition of PDE4 enzymes was conducted with the synthetic agents (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In addition, binding affinity of each compound (i.e., <i>K</i><sub>i</sub> value) was calculated from the IC<sub>50</sub> value and measured for each compound by assessing the potency of inhibition of binding radiolabeled <b>25</b> (RTI-55)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to the hDAT, hSERT, and hNET<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In vitro functional potency was measured by determining the reuptake inhibition (i.e., IC<sub>50</sub> value) of [<sup>3</sup>H]-DA, [<sup>3</sup>H]-5-HT, or [<sup>3</sup>H]-NE at the recombinant hDAT, hSERT, or hNET in the presence of HEK-293 cells transfected with the respective transporter cDNA.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Recombinant PDE4 Isoforms with PDE4 Inhibitors and Dual PDE4 Inhibitor/SSRIs</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">enzyme</th></tr><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="middle" char=".">human PDE4D3 <i>K</i><sub>i</sub> (nM)</th><th align="center" valign="middle">human PDE4B3 <i>K</i><sub>i</sub> (nM)</th><th align="center" valign="middle">human PDE4A1 <i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>19</b></td><td align="char" char=".">6.3</td><td align="left">250</td><td align="left">>1000</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="char" char=".">2.3</td><td align="left">ND<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">2.0</td><td align="left">199</td><td align="left">>1000</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">1.2</td><td align="left">500</td><td align="left">>1000</td></tr><tr valign="top"><td align="left">Rolipram</td><td align="char" char=".">58.9</td><td align="left">ND</td><td align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">ND, not done.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Radioligand Binding and [<sup>3</sup>H] Neurotransmitter Uptake in HEK-hDAT, HEK-hSERT, and HEK-hNET Cells<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">binding (<i>K</i><sub>i</sub>, nM)</th><th colspan="3" align="center" valign="middle">reuptake (IC<sub>50</sub>, nM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">description</th><th align="center" valign="middle">hDAT</th><th align="center" valign="middle">hSERT</th><th align="center" valign="middle">hNET</th><th align="center" valign="middle">hDAT</th><th align="center" valign="middle">hSERT</th><th align="center" valign="middle">hNET</th></tr></thead><tbody><tr valign="top"><td align="left">cocaine</td><td align="left"> </td><td align="left">371 ± 81</td><td align="left">276 ± 87</td><td align="left">1115 ± 198</td><td align="left">303 ± 74</td><td align="left">416 ± 135</td><td align="left">835 ± 229</td></tr><tr valign="top"><td align="left">Fluoxetine<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></td><td align="left"> </td><td align="left">6670 ± 850</td><td align="left">1.1 ± 0.5</td><td align="left">1560 ± 300</td><td align="left">19500 ± 7600</td><td align="left">7.3 ± 2.9</td><td align="left">1020 ± 180</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">SSRI</td><td align="left">6500 ± 828</td><td align="left">2.1 ± 0.2</td><td align="left">2440 ± 215</td><td align="left">27850 ± 5129</td><td align="left">2.5 ± 0.6</td><td align="left">481 ± 158</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">SSRI</td><td align="left">7307 ± 1331</td><td align="left">1.1 ± 0.1</td><td align="left">10600 ± 1880</td><td align="left">16987 ± 1352</td><td align="left">2.3 ± 0.6</td><td align="left">1930.0 ± 463.0</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">PDE4 inhibitor</td><td align="left">>100000</td><td align="left">>100000</td><td align="left">>100000</td><td align="left">>100000</td><td align="left">>100000</td><td align="left">>100000</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">N-modified PDE4 inhibitor</td><td align="left">>100000</td><td align="left">>100000</td><td align="left">39119 ± 4915</td><td align="left">>100000</td><td align="left">>100000</td><td align="left">>100000</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">dual inhibitor</td><td align="left">2478 ± 451</td><td align="left">156 ± 30</td><td align="left">1748 ± 257</td><td align="left">3556 ± 377</td><td align="left">127 ± 15</td><td align="left">957 ± 146</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">dual inhibitor</td><td align="left">5340 ± 1083</td><td align="left">194 ± 87</td><td align="left">7441 ± 1269</td><td align="left">5340 ± 1083</td><td align="left">194 ± 87</td><td align="left">7441 ± 1269</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">SSRI</td><td align="left">66988 ± 14450</td><td align="left">21.2 ± 4.3</td><td align="left">19332 ± 3577</td><td align="left">>100000</td><td align="left">18.4 ± 6.1</td><td align="left">20370 ±  3751</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Values are the mean ± SEM of three to four independent experiments conducted with duplicate (binding) or with triplicate (uptake) determinations unless the mean of three experiments exceeded 100 μM. Drug inhibition of [<sup>125</sup>I]<b>-25</b> binding in HEK-hDAT, HEK-hSERT, or HEK-hNET cell membranes. Inhibition of [<sup>3</sup>H]-DA, [<sup>3</sup>H]-5-HT, [<sup>3</sup>H]-NE in the presence of HEK-hDAT, HEK-hSERT, or HEK-hNET cells, respectively;</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> PDE4 Inhibitors</h3><div class="NLM_p">Compound <b>19</b> and rolipram are known PDE4 inhibitors, and we confirmed this observation (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It was known that <i>N</i>-substitution was beneficial for PDE4 inhibition potency,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and in the phthalazinone series, the <i>cis</i>-(±)-4a,5,8,8a-tetra- and <i>cis</i>-(±)-4a,5,6,7,8,8a-hexahydro-2<i>H</i>-phthalazin-1-ones showed potent inhibition of PDE4 by occupying a region of space different from that of other fused ring systems to afford selective inhibition.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a><i>N</i>-Substituted derivatives distal to the fused ring system were synthesized to examine whether additional pharmacological properties could be introduced into <b>19</b> while still preserving PDE4 inhibitory activity. In fact, the <i>N</i>-substituted phthalazinone <b>20</b> was a more potent inhibitor of PDE4D3 than was <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Thus, a template with potent PDE4 inhibitory activity was chemically combined with a molecule possessing potent SSRI function to make a compound with a dual PDE4 inhibition/SSRI reuptake inhibition profile.</div><div class="NLM_p last">The pattern of effects of PDE4 inhibitors on behavior is distinct from that of selective inhibitors of other PDE families.<a onclick="showRef(event, 'ref9 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref14">(9, 14)</a> Generalized increases in cAMP do not adequately explain the behavioral effects of PDE4 inhibitors. Thus, changes in cAMP signaling in particular pathways (e.g., β adrenergic or NMDA receptor-mediated signaling) result in the pattern of behavioral changes observed.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> There are four PDE4 genes (i.e., <i>PDE4A</i>, <i>PDE4B</i>, <i>PDE4C</i>, and <i>PDE4D</i>). The enzyme PDE4C is mainly in the periphery and was not studied herein<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> but PDE4A, PDE4B, and PDE4D are present in the brain and their distribution suggest distinct roles in neuropsychopharmacology. Repeated treatment of animals with the antidepressant desipramine (C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>), which indirectly stimulates β receptors alters PDE4A and PDE4B expression.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The PDE4 inhibitor rolipram does not produce antidepressant-like effects in PDE4D knockout mice and PDE4D may play a role in pharmacotherapy of depression.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Consequently, the inhibition of these PDE4 forms was studied (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Selective Serotonin Reuptake Inhibitors</h3><div class="NLM_p last">Compounds <b>14</b> and <b>15</b> were derived from molecular dissection of aryltropanes<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and were potent inhibitors of serotonin reuptake (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compounds <b>14</b> and <b>15</b> were potent inhibitors of radiolabeled <b>25</b> binding to the hSERT (i.e., <i>K</i><sub>i</sub> values of 2.1 and 1.1 nM, respectively) and reuptake (i.e., <i>K</i><sub>i</sub> values of 2.5 and 2.3 nM, respectively) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compounds <b>14</b> and <b>15</b> were equal to or more potent and selective than fluoxetine in reuptake inhibition of the hSERT. For <b>14</b> and <b>15</b>, the selectivity of either binding potency or reuptake efficacy for hSERT was very great. Thus, the binding selectivity ratios <i>K</i><sub>i</sub>(hDAT)/<i>K</i><sub>i</sub>(hSERT) and <i>K</i><sub>i</sub>(hNET)/<i>K</i><sub>i</sub>(hSERT) for <b>14</b> and <b>15</b> were 3095 and 1162 and 6642 and 9636, respectively. The reuptake inhibition selectivity ratios IC<sub>50</sub>(hDAT)/IC<sub>50</sub>(hSERT) and IC<sub>50</sub>(hNET)/IC<sub>50</sub>(hSERT) for <b>14</b> and <b>15</b> were 11140 and 192 and 7386 and 839, respectively. Compounds related to the PDE4 inhibitor (i.e., <b>19</b> and <b>20</b>) were ineffective at inhibiting <b>25</b> binding to the hDAT, hSERT, or hNET (i.e., <i>K</i><sub>i</sub> values 39−100 μM).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Dual PDE4 Inhibitor/SSRIs</h3><div class="NLM_p">Compounds <b>19</b>, <b>21</b>, and <b>22</b> were tested for inhibition of cAMP hydrolysis by recombinant forms of human PDE4D3, human PDE4B3, and human PDE4A1, in vitro. The <i>K</i><sub>i</sub> value for inhibition of human PDE4D3 for rolipram, <b>19</b>, <b>21</b>, and <b>22</b> was 58.9, 6.3, 2.0, and 1.2 nM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The increase in potency for <b>21</b> and <b>22</b> compared with <b>19</b> suggested that <i>N</i>-substitution increased inhibition of human PDE4D.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> For human PDE4B3, the <i>K</i><sub>i</sub> values for inhibition of cAMP hydrolysis of <b>19</b>, <b>21</b>, and <b>22</b> were 250, 199, and 500 nM, respectively. In the case of human PDE4A1, compounds <b>19</b>, <b>21</b>, and <b>22</b> all showed <i>K</i><sub>i</sub> values for inhibition of cAMP hydrolysis with values greater than 1 μM. Thus, <b>19</b>, <b>21</b>, and <b>22</b> possessed considerable inhibitory selectivity for PDE4D.</div><div class="NLM_p last">The dual PDE4 inhibitor/SSRIs (i.e., compounds <b>21</b> and <b>22</b>) were moderately potent inhibitors of binding of radiolabeled <b>25</b> to the hSERT having <i>K</i><sub>i</sub> values of 156 and 194 nM, respectively. For compounds <b>21</b> and <b>22</b>, inhibition of neurotransmitter reuptake was highly selective for the hSERT (i.e., IC<sub>50</sub> values of 127 and 194 nM, respectively) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). For <b>21</b> and <b>22</b>, the selectivity of either binding potency or reuptake efficacy was greatest for hSERT. Finally, the data showed that dual PDE4 inhibitor/SSRIs <b>21</b> and <b>22</b> were relatively selective for the hSERT and did not potently interact with hDAT or hNET (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Studies</h3><div class="NLM_p">The PDE4 inhibitor (i.e., <b>19</b>), the SSRI (i.e., <b>14</b>), and the dual PDE4 inhibitor/SSRI (i.e., <b>21</b>) were separately examined for acute and subchronic antidepressant-like effects in vivo. The two compounds were not administered in combination. Acute treatment of inbred Charles River (ICR) mice with either <b>19</b> or <b>21</b>, at doses of 0.3 and 3 mg/kg, decreased duration of immobility in a dose-dependent manner in the forced-swim test (FST)<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compared to vehicle control, the higher dose of <b>19</b> or <b>21</b> (3 mg/kg) significantly decreased immobility in the FST (<i>P</i> < 0.05). In contrast, acute administration of fluoxetine (40 mg/kg) or repeated treatment with rolipram (0.5 mg/kg, ip, once a day for 8 days) (data not shown), was required to produce similar antidepressant-like effects in the FST. On a molar basis, compound <b>21</b> (0.5 μmol/kg) was 129-fold more efficacious than fluoxetine (65 μmol/kg) in the FST to give the same effect. Acute treatment with rolipram (0.5 mg/kg, data not shown) did not alter FST behavior in agreement with the literature.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The SSRI, compound <b>14</b>, at the doses used (i.e., 10 and 30 mg/kg) tended to decrease immobility, but this effect was not statistically significant (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effect of acute treatment of test compounds on immobility in the forced-swim test in ICR mice: (A) compound <b>14</b> (10 mg/kg, 37 μmol/kg and 30 mg/kg, 112 μmol/kg), (B) compound <b>19</b> (0.3 mg/kg, 1.0 μmol/kg and 3 mg/kg, 10 μmol/kg), and (C) compound <b>21</b> (0.3 mg/kg, 0.5 μmol/kg and 3 mg/kg, 5 μmol/kg). Vehicle (Veh) or test agent was injected ip 30 min prior to the test. <i>n</i> = 9−11; * <i>P</i> < 0.05 vs Veh.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because Balb/c mice have been reported to exhibit a relatively high immobility baseline and are sensitive to fluoxetine challenge in the FST,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the in vivo studies described above were repeated. Acute administration of fluoxetine (20 mg/kg), <b>14</b> (10 mg/kg), or <b>15</b> (10 mg/kg) did not markedly alter the duration of immobility in the FST in Balb/c mice (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In contrast, subchronic administration of a lower dose of fluoxetine (10 mg/kg) significantly decreased immobility (<i>P</i> < 0.05). However, subchronic treatment with <b>14</b> (10 mg/kg) or <b>21</b> (1 mg/kg) did not change immobility compared to vehicle control (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). It is possible that the lack of in vivo activity for <b>14</b> or <b>15</b> was a consequence of metabolic instability. To test this possibility, the in vitro metabolic stability of <b>14</b>, <b>15</b>, <b>19</b>, <b>21</b>, <b>22</b>, and <b>24</b> was examined.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of acute treatment with fluoxetine (20 mg/kg, 65 μmol/kg), compound <b>14</b> (10 mg/kg, 37.4 μmol/kg), and compound <b>15</b> (10 mg/kg, 35.5 μmol/kg) on immobility in the forced-swim test in Balb/c mice. Vehicle or test agent was injected ip 30 min prior to the test. <i>n</i> = 10−11.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of subchronic administration of fluoxetine (10 mg/kg, 32.3 μmol/kg), compound <b>14</b> (10 mg/kg, 37.4 μmol/kg), and compound <b>21</b> (1.0 mg/kg, 1.6 μmol/kg) on immobility in the forced-swim test in Balb/c mice. Vehicle or the test agent was injected ip 23, 5, and 1 h prior to the test. <i>n</i> = 10−11; * <i>P</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Metabolic Studies</h3><div class="NLM_p">The in vitro metabolism of compounds <b>14</b> and 2-{5-[3-(5-fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-methyl-amine (<b>24</b>) were examined in the presence of mouse and human liver microsomes supplemented with NADPH to examine the metabolic stability of the compounds and because metabolism plays a large role in the pharmacological activity of SSRIs. We hypothesized that by blocking a prominent route of metabolism of SSRIs (i.e., aliphatic amine metabolism), a more efficacious agent could be obtained. Compounds <b>19</b>, <b>21</b>, and <b>22</b> were examined in the presence of mouse and human liver microsomes supplemented with NADPH. An efficient HPLC method was established to afford separation of the starting material from any putative metabolites (e.g., aldehyde, hydroxylamine, nitrone). Aerobic incubations of <b>14</b> and <b>24</b> in the presence of mouse and rat liver microsomes supplemented with NADPH showed a time-dependent loss of substrate. For <b>14</b> and <b>24</b>, the calculated half-life was 56 or 106 and 58 or 129 min, respectively, in the presence of mouse and rat liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In the presence of mouse liver microsomes, compounds <b>19</b> and <b>21</b> showed considerable metabolic stability, having calculated half-lives of 211 and 154 min, respectively. Compound <b>21</b> was not detectably metabolized in the presence of human liver microsomes. No detectable metabolic instability of compound <b>22</b> was observed in the presence of either mouse or human liver microsomes up to 60 min (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), and we judged these compounds were metabolically stable enough to undertake in vivo studies. Lack of efficacy of <b>14</b> and <b>15</b> was likely not due to metabolism.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Hepatic Microsomes on the Metabolic Stability of SSRIs, PDE4 Inhibitors, and Dual PDE4 inhibitor/SSRIs</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char=".">RLM<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a><i>t</i><sub>1/2</sub> (min)</th><th align="center" valign="middle" char=".">MLM<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a><i>t</i><sub>1/2</sub> (min)</th><th align="center" valign="middle" char=".">HLM<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a><i>t</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>14</b></td><td align="char" char=".">106.3</td><td align="char" char=".">56.0</td><td align="char" char=".">NA<a class="ref internalNav" href="#tbl3-fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="char" char=".">NA</td><td align="char" char=".">211.3</td><td align="char" char=".">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">NA</td><td align="char" char=".">153.9</td><td align="char" char=".">ND</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">NA</td><td align="char" char=".">ND</td><td align="char" char=".">ND</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="char" char=".">129.0</td><td align="char" char=".">58.5</td><td align="char" char=".">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">RLM, rat liver microsomes.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">MLM, mouse liver microsomes.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">HLM, human liver microsomes.</p></div><div class="footnote" id="tbl3-fn4"><sup>d</sup><p class="last">NA, not available.</p></div><div class="footnote" id="tbl3-fn5"><sup>e</sup><p class="last">ND, no detectable degradation observed in the presence of animal liver microsomes supplemented with NADPH for 60 min.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A dual PDE4 inhibitor/SSRI was synthesized by linking an SSRI with a PDE4 inhibitor via a five-carbon linker. Previously, it was shown that the potency of PDE4 inhibition of <b>19</b> was not diminished by addition of lipophilic bulk to the phthalazin-1-one nitrogen atom and <b>20</b> was a more potent PDE4D3 inhibitor than <b>19</b>. Thus, elaboration of <b>21</b> and <b>22</b> afforded PDE4 inhibitors linked to an SSRI that retained considerable pharmacological activity. Compared to <b>19</b>, compounds <b>21</b> and <b>22</b> possessed more potency at inhibiting PDE4. The dual PDE4 inhibitor/SSRIs <b>21</b> and <b>22</b> possessed considerable potency for inhibition of binding of <b>25</b> and inhibition of 5-HT reuptake in the presence of the hSERT. Compared to <b>14</b> and <b>15</b>, however, some functional activity was lost. Because studies have shown that the <i>trans</i> diastereomer of <b>14</b> or <b>15</b> possess about 7-fold more hSERT reuptake inhibition activity than the <i>cis</i> diastereomer (unpublished data) preparation of a dual inhibitor with only the <i>trans</i> diastereomer should increase potency. While some loss of in vitro binding potency and reuptake inhibition of the hSERT was observed in chemically linking SSRIs <b>14</b> and <b>15</b> to compound <b>20</b>, nevertheless, significant in vitro activity was retained.</div><div class="NLM_p">A dual PDE4 inhibitor/SSRI offers advantages beyond simple additive effects of coadministration of the individual agents including providing greater symptomatic efficacy and better utility. The “message-address” concept of a dual agent could afford proximal inhibition of PDE4, thus keeping ample cAMP concentrations present near the activated transporter for greater functional selectivity. Decrease in the catabolism of cAMP might be expected to increase the sensitivity to and effectiveness of SSRI antidepressants. Evidence points to the PDE4D subtype as an important component of the signaling pathway involved in mediation of antidepressant effects on behavior. Dual PDE4 inhibitor/SSRIs can affect local control of 5-HT and cAMP in a stimulus-selective manner because of the compartmentalization of the PDE enzymes. In fact, acute treatment of animals with fluoxetine that elevated synaptic 5-HT and NE but not DA levels significantly enhanced rolipram binding and retention.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> By chemically combining a selective PDE4 inhibitor with an SSRI, synergistic antidepressant effects might be observed.</div><div class="NLM_p">The greater PDE4 inhibitor potency of the dual agent will allow lower doses to be used and decrease side effects. Because CNS disorders are recognized as polyetiological in nature, drugs that modulate multiple targets will contribute to the multifactorial processes in disease treatment. PDE4D inhibition results in a pattern of behavior that is indicative of an antidepressant-like effects.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> This suggests that PDE4D is critical in mediating the antidepressant-like effects of PDE4 inhibitors. The PDE4 inhibitor <b>19</b> and the dual PDE4 inhibitor/SSRI <b>21</b> at doses of 0.3 and 3 mg/kg, respectively, decreased duration of immobility in the FST in a dose-dependent manner in ICR mice. Compared to vehicle control, 3 mg/kg significantly decreased immobility in the FST (<i>P</i> < 0.05). Acute administration of <b>14</b> decreased immobility in the FST, but this did not reach statistical significance. In contrast, 40 mg/kg of fluoxetine or repeated treatment with rolipram (0.5 mg/kg, ip, once a day for 8 days) was required to produce similar antidepressant-like effects in the FST; acute treatment with 0.5 mg/kg rolipram did not alter FST behavior.</div><div class="NLM_p">Acute administration of fluoxetine (20 mg/kg) or <b>14</b> (10 mg/kg) did not alter the duration of immobility in the FST in Balb/c mice, but SSRIs are known to not significantly affect changes in FST after acute administration. In contrast, subchronic administration of a lower dose of fluoxetine (10 mg/kg) significantly decreased immobility (<i>P</i> < 0.05). However, subchronic treatment with <b>14</b> or <b>15</b> (10 or 1 mg/kg, respectively) did not change immobility compared to the vehicle control.</div><div class="NLM_p last">In summary, we hypothesize that dual PDE4 inhibitor/SSRIs offer an advantage over simple additive effects of coadministered agents. Dual PDE4 inhibitor/SSRIs offer the advantage of blocking the effect of the up-regulation of PDE4 in a compartmentalized manner. While PDE4 expression will still increase, its hydrolytic activity will be blocked. Thus, the overall increase in serotonin receptor-mediated cAMP signaling will be preserved with repeated treatment. Moreover, we suggest that compounds such as <b>21</b> show the utility of addressing multiple targets to alleviate complex disease such as depression.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p last">Chemicals used in this study were of the highest purity available. Commercially available reagents including 2-methoxy-5-fluoro benzaldehyde were purchased from Aldrich Chemical Co. (Milwaukee, WI) or VWR (San Diego, CA) and were used as received. All moisture sensitive reactions were carried out in flame-dried glassware under an argon atmosphere. Tetrahydrofuran (THF) and toluene were freshly distilled from calcium hydride under an argon atmosphere. Methanol (CH<sub>3</sub>OH) was passed through a column of neutral alumina and stored over 3 Å molecular sieves prior to use. Rolipram, fluoxetine, diethyleneaminetetracetic acid (DETAPAC), and all the compounds of the NADPH-generating system were obtained from Sigma Chemical Company (St. Louis, MO). Human liver, pooled female liver, and pooled male rat liver microsomes were purchased from BD Gentest Corp. (Woburn, MA). The human liver microsomes had the following functional activities (nmol/min/mg of protein): phenacetin <i>O</i>-deethylase (0.18), coumarin 7-hydroxylase (2.0), (<i>S</i>)-mephenytoin <i>N</i>-demethylase (0.05), diclofenac 4′-hydroxylase (1.9), (<i>S</i>)-mephenytoin 4′-hydroxylase (0.03), bufuralol 1′-hydroxylase (0.12), chlorzoxazone 6-hydroxylase (1.5), testosterone 6β-hydroxylase (4.6), and methyl <i>p</i>-tolyl sulfide oxidase (4.3). The pooled male rat liver microsomes had the following functional activities (nmol/min/mg of protein): testosterone 6β-hydroxylase (5.8) and nicotine oxidase (2.2). The pooled female mouse liver microsomes had the following functional activities (nmol/min/mg of protein): 7-ethoxyresorufin <i>O</i>-deethylase (0.39), <i>p</i>-nitrophenol hydroxylase (1.9), lauric acid-hydroxylase (0.86), and testosterone 6β-hydroxylase (5.0). Cocaine was provided by the National Institute on Drug Abuse, NIH (Bethesda, MD). Compound <b>25</b> was a kind gift of Dr. Ivy Carroll (RTI, Research Triangle Park, NC). [<sup>3</sup>H]-DA, [<sup>3</sup>H]-5-HT, [<sup>3</sup>H]-NE, and [<sup>125</sup>I]-<b>25</b> were purchased from Perkin-Elmer Life Sciences (Boston, MA). The preparation of the hDAT used was described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The hSERT cDNA and HEK cells transfected with hNET cDNA was generously supplied by Dr. Randy Blakely (Vanderbilt University, Nashville, TN). Analytical thin-layer chromatography (TLC) was done on K6F silica gel 60 Å glass-backed plates from Whatman (Clifton, NJ). Compounds were detected using UV absorption at 254 nm and/or stained with I<sub>2</sub> (iodine). Flash chromatography was done on (60 Å) pore silica gel from E. Merck (Darmstadt, Germany).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Instrument Analysis</h3><div class="NLM_p">NMR spectra were recorded with a Bruker spectrometer operating at 500 MHz (NuMega Resonance Laboratories, Inc., San Diego, CA) or at 300 MHz by an in-house Varian spectrometer (Palo Alto, CA) using the solvent specified. Chemical shifts were reported in parts per million (ppm, δ) using residual solvent signals as internal standards. Low resolution mass spectroscopy (LRMS) was done with an HP 1100 mass spectrometer (HT Laboratories, San Diego, CA) using electrospray ionization (ESI) or with an in-house Hitachi M-8000 3DQMS (ion trap) mass spectrometer using ESI. High resolution mass spectroscopy (HRMS) was done with a Micromass LCT time-of-flight mass spectrometer at the University of Montana Mass Spectral Facility (Missoula, MT) using ESI.</div><div class="NLM_p last">The 2,5-disubstituted tetrahydrofurans and the dual PDE4 inhibitor/SSRIs were characterized by <sup>1</sup>H NMR, LRMS, and HRMS and their purities (>95%) were quantified by HPLC in two distinct solvent systems. Analytical HPLC measurements were run on a Hitachi L-6200 system equipped with a Hitachi L-7400 UV detector. Separations were done with a 5 μm, 4.6 mm × 250 mm, Axxi-chrom silica column (Richard Scientific, Novato, CA) or with a 5 μm, 4.6 mm × 250 mm Supelco HS F5 pentafluorophenyl column (Supelco Inc., Bellefonte, PA). HPLC analysis is described in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. <sup>1</sup>H NMR and mass spectra were consistent with the assigned structures.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Transporter Binding Assays</h3><div class="NLM_p last">HEK-hDAT, -hSERT, or -hNET cells were grown until confluent as described previously.<a onclick="showRef(event, 'ref20 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref24">(20, 24)</a> Cells were scraped from plates and centrifuged for 20 min at 30000<i>g</i> and the pellet was resuspended in 0.32 M sucrose with a Polytron at a setting of 1 for 5 s. Assays contained 50 μL of membrane preparation, 25 μL of the test compound and 25 μL of [<sup>125</sup>I]-<b>25</b> (40−80 pM final concentration) in a final volume of 250 μL Krebs HEPES buffer (25 mM HEPES, 122 mM NaCl, 5 mM KCl, 1.2 mM MgSO<sub>4</sub>, 2.5 mM CaCl<sub>2</sub>, 1 μM pargyline, 100 μM tropolone, 2 mg glucose/mL, and 0.2 mg ascorbic acid/mL at pH 7.4.). Membranes were preincubated with test compounds for 10 min before addition of [<sup>125</sup>I]<b>-25</b>. Specific binding was determined as the difference in binding observed in the presence and absence of 5 μM mazindol (HEK-hDAT and hNET) or 5 μM imipramine (HEK-hSERT). The incubations were done in the dark and terminated by filtration onto a Whatman GF/C filters using a 96-well Tomtech cell harvester (Tomtech, Orange, CT). Scintillation fluid was added to each filter spot and radioactivity remaining on the filter was determined using a Wallace β-plate reader (Wallace Laboratories, Cranbury, NJ). Specific binding was defined as the difference in binding in the presence and absence of 5 μM mazindol (hDAT and hNET) or 5 μM imipramine (hSERT).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Inhibition of Substrate Uptake</h3><div class="NLM_p last">HEK-hDAT, -hSERT, or -hNET cells were grown as described above. Cells were scraped from the plates and suspended cells were added to a 96-well plate containing test compounds and Krebs-HEPES buffer in a final assay volume of 0.5 mL. After a 10 min preincubation in a 25 °C water bath, [<sup>3</sup>H]-labeled neurotransmitter (50 μL, 20 nM final concentration) was added and the assay was initiated. After 10 min, the incubation was terminated by filtration onto GF/C filters presoaked with 0.05% polyethylenimine using a Tomtech call harvester and radioactivity remaining on the filters was determined as described above. Specific uptake was defined as the difference in uptake in the presence and absence of 5 μM mazindol (hDAT and hNET) or 5 μM imipramine (hSERT).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> PDE4 Assay</h3><div class="NLM_p last">PDE4 enzyme assays were carried out as described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Studies with recombinant PDE4 enzymes were carried out in the laboratory of Professor Marco Conti (Stanford University, Palo Alto, CA).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Data Analysis</h3><div class="NLM_p last">GraphPad Prism (GraphPad Software, San Diego, CA) was used to determine the saturation and binding kinetic data. IC<sub>50</sub> values were converted to <i>K</i><sub>i</sub> values using the Cheng−Prusoff equation.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Mouse and Rat Liver Microsome Stability Assay</h3><div class="NLM_p last">Microsomal incubations (final volume 0.25 mL) with the SSRIs, dual PDE4 inhibitor/SSRIs or PDE4 inhibitor was done with an HPLC assay as described above. Diluted stocks of either mouse, human, or rat liver microsomes (0.5 mg of protein), 100 μM potassium phosphate buffer (pH 7.4), 0.5 mM NADP<sup>+</sup>, 0.5 mM glucose-6-phosphate, 5 IU/mL glucose-6-phosphate dehydrogenase, 0.6 mM DETAPAC, and 3 mM MgCl<sub>2</sub> were combined and placed on ice. For a metabolic stability assay, either vehicle or 40 μM test compound was added and the incubation was initiated at 37 °C with constant shaking. After 0, 10, 25, 40, and 60 min, the incubations were stopped by the addition of 1 mL CH<sub>2</sub>Cl<sub>2</sub>/2-propanol (3:1, v:v). After thorough mixing, the organic layer was separated from the aqueous portion by centrifugation at 12000<i>g</i>. The organic material was evaporated with a stream of argon. The residue was dissolved in methanol (200 μL), and the sample was analyzed by HPLC.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vivo Evaluation of Selected Compounds</h3><div class="NLM_p last">Separate nonhabituated male mice were used in the conduct of this work. Fully approved animal protocols were used and the studies were done in keeping with the NIH standards for use of experimental animals.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Experiment 1</h3><div class="NLM_p last">Forty male ICR mice, weighing 26.2 ± 0.3 g, were housed in a temperature-controlled room (22−23 °C) and maintained on a 12 h on/12 h off light cycle (lights on at 6:00 a.m.). Water and food were freely available in the home cages. The mice were randomly divided into four groups: (A) vehicle, (B) compound <b>14</b>, (C) compound <b>19</b>, and (D) compound <b>21</b> and administered compounds were dissolved in 0.9% saline containing 5% dimethyl sulfoxide (DMSO). Saline containing the same percentage of DMSO was used as vehicle. The lower doses (i.e., 0.3 mg/kg for <b>19</b> and <b>21</b> or 10 mg/kg for <b>14</b>) were tested followed by the larger doses (3 mg/kg for <b>19</b> and <b>21</b> or 30 mg/kg for <b>14)</b> 1 week later, when the mice were again randomly divided into four groups as described above (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The forced-swim test (FST) was carried out as described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Mice were given a swimming pretest session once a day for two successive days. Then 24 hours after the last session, mice were injected with vehicle or the lower dose of each test compound by the ip route 30 min prior to the FST. One week later, administration of the larger dose of each of the test compounds was repeated. During the pretest and test sessions, each mouse was placed for 6 min in a plastic cylinder (45 cm high × 20 cm diameter), which was filled to a depth of 28 cm with water (23 ± 1 °C). The duration of immobility, which was defined as floating in an upright position without additional activity other than that necessary for the animal to keep its head above water, was recorded.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> In a control experiment, acute administration of fluoxetine (40 mg/kg) or repeated treatment with rolipram (0.5 mg/kg, ip, once a day for 8 days, was required to produce similar antidepressant-like effects in the FST (data not shown).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Experiment 2</h3><div class="NLM_p last">Forty Balb/c male mice weighing 22.4 ± 0.1 g were used in this experiment, which was carried out in two sessions. In each session, the mice were divided into four groups: (A) vehicle (saline containing 5% DMSO), (B) fluoxetine, 20 mg/kg, (C) compound <b>21</b>, 10 mg/kg, and (D) compound <b>14</b>, 10 mg/kg for the first session and (A) vehicle, (B) Fluoxetine, 10 mg/kg, (C) compound <b>14</b>, 10 mg/kg, and (D) compound <b>21</b>, 10 mg/kg for the second session, which was carried out 4 weeks later. Mice in the first session (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) were treated with vehicle or the test agents acutely, whereas mice in the second sessions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) were treated subchronically, i.e., vehicle or drugs were given ip 23, 5, and 1 h before the FST. The experiment was done similar to Experiment 1 except for the pretest training, which was not carried out in the second session.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vivo Statistics</h3><div class="NLM_p last">All in vivo data were analyzed by one-way analyses of variance (ANOVA) followed by Dunnett’s tests for post hoc comparisons of individual means.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis</h3><div id="sec4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Ethyl-3-(2′- Methoxy-5′-fluorophenyl)-2-propenoate (<b>2</b>)</h4><div class="NLM_p last">To a solution of 2-methoxy-5-fluoro benzaldehyde (4.3 g, 28.0 mmol, 1 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (30 mL) at 0 °C was added carbethoxymethylenetriphenylphosphorane (10.7 g, 30.1 mmol, 1.1 equiv) portionwise and the reaction was warmed to room temperature and stirred for 12 h. The solvent was then removed in vacuo, and the residue was purified by flash column chromatography (EtOAc/hexane, 10:90, v:v, <i>R</i><sub>f</sub> = 0.2) to yield the product (6.0 g, 95%) as a 4:1 mixture of <i>trans</i>/<i>cis</i> diastereomers. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 7.93 (d, <i>J</i> = 16.2 Hz, 0.8 H), 7.33 (dd, <i>J</i> = 3.1, 9.2 Hz, 0.2 H), 7.21 (dd, <i>J</i> = 3.1, 9.2, Hz, 0.8 H), 7.08 (d, <i>J</i> = 12.5 Hz, 0.2 H), 7.03 (dt, <i>J</i> = 3.0, 8.8 Hz, 0.8 H), 6.99 (dt, <i>J</i> = 3.0, 8.8 Hz, 0.2 H), 6.84 (dd, <i>J</i> = 3.1, 8.6 Hz, 0.8 H), 6.79 (dd, <i>J</i> = 3.3, 9.1 Hz, 0.2 H), 6.47 (d, <i>J</i> = 16.2 Hz, 0.8 H), 5.99 (d, <i>J</i> = 12.5 hz, 0.2 H), 4.25 (q, <i>J</i> = 7.1 Hz, 1.6 H), 4.15 (q, <i>J</i> = 7.0 Hz, 0.4 H), 3.86 (s, 2.4 H), 3.81 (s, 0.6 H), 1.34 (t, <i>J</i> = 7.1 Hz, 2.4 H), 1.22 (t, <i>J</i> = 7.0 Hz, 0.6 H).</div></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Ethyl-4-(5′-fluoro-2′-methoxyphenyl)propanoate (<b>3</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (6.0 g, 27.0 mmol, 1 equiv) in ethanol (200 proof, 40 mL) under Ar was added Pd/C (10%, 250 mg, 0.1 equiv), and the flask containing the mixture was evacuated and purged with H<sub>2</sub> three times. H<sub>2</sub> was attached to the flask and the reaction was allowed to stir for 15 h at room temperature. The reaction mixture was filtered through a pad of silica and eluted with EtOAc/hexane, 50:50, v:v. The crude product obtained by removal of the solvent in vacuo was purified by a flash column chromatography (EtOAc/hexane, 10:90, v:v, <i>R</i><sub>f</sub> = 0.27) to give the product (5.8 g, 95%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.89−6.84 (m, 2 H), 6.74 (dd, <i>J</i> = 4.7, 9.8 Hz, 1 H), 4.12 (q, <i>J</i> = 7.1 Hz, 2 H), 3.79 (s, 3 H), 2.91 (t, <i>J</i> = 7.7 Hz, 2 H), 2.59 (t, <i>J</i> = 7.7 Hz, 2 H), 1.24 (t, <i>J</i> = 7.2 Hz, 3 H).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(5′-Fluoro-2′-methoxyphenyl)propanal (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>3</b> (5.8 g, 25.7 mmol, 1 equiv) in dry toluene (40 mL) under an atmosphere of Ar was added a DIBAL solution (1 M in toluene, 30 mL, 30 mmol, 1.2 equiv) at −78 °C. The reaction was stirred at −78 °C for 2 h. Methanol (2 mL) was then added to the mixture, and the reaction was allowed to warm to 0 °C. The reaction mixture was then poured into a separatory funnel containing HCl solution (1 N, 100 mL). The organic fraction was extracted with EtOAc (3 × 60 mL), and the combined organic layers were washed with brine (80 mL) and dried over sodium sulfate. The crude product obtained by removal of the solvent in vacuo was purified by flash column chromatography (EtOAc/hexane, 10:90, v:v, <i>R</i><sub>f</sub> = 0.1) to give the product (3.1 g, 66%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 9.80 (s, 1 H), 6.88−6.86 (m, 2 H), 6.75 (dd, <i>J</i> = 4.6, 8.6 Hz, 1 H), 3.79 (s, 3 H), 2.91 (t, <i>J</i> = 7.4 Hz, 2 H), 2.72 (t, <i>J</i> = 7.4 Hz, 2 H).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(5′-Fluoro-2′-methoxyphenyl)-4-ethylenedioxy-1-butene (<b>5</b>)</h3><div class="NLM_p last">To a suspension of 2-(1,3-dioxolan-2-yl)ethyltriphenylphosphonium bromide (5.0 g, 11.3 mmol, 1 equiv) in THF (30 mL) under an atmosphere of Ar was added NaH (60% in mineral oil, 0.48 g, 11.3 mmol, 1 equiv), and the mixture obtained was heated to reflux for 1 h. The orange suspension obtained was cooled to 0 °C and 5-fluoro-2-methoxybenzaldehyde (1.54 g, 10 mmol, 0.9 equiv) was added and the reaction was warmed to room temperature and continued with stirring for 12 h. The reaction mixture was poured into a separatory funnel containing ammonium chloride aqueous solution (sat. NH<sub>4</sub>Cl/H<sub>2</sub>O 50:50, v:v, 50 mL). The organic material was extracted with EtOAc (3 × 80 mL), and the combined organic layers were washed with brine (60 mL) and dried over sodium sulfate. The solvent was then removed in vacuo and the crude product obtained was purified by flash column chromatography (EtOAc/hexane, 7:93, v:v, <i>R</i><sub>f</sub> = 0.15) to give the product (2.63 g, 66%) as a 4:1 mixture of <i>cis</i> and <i>trans</i> diastereomers. <sup>1</sup>H NMR (major isomer) (CDCl<sub>3</sub>, 500 MHz): δ 7.08 (dd, <i>J</i> = 3.1, 8.7 Hz, 1 H), 6.93 (dt, <i>J</i> = 3.1, 8.7 Hz, 1 H), 6.78 (dd, <i>J</i> = 4.3, 8.7 Hz, 1 H), 6.63 (d, <i>J</i> = 11.9 Hz, 1 H), 5.83 (td, <i>J</i> = 7.3 Hz, 11.9 Hz, 1 H), 4.99 (t, <i>J</i> = 4.6 Hz, 1 H), 4.02−3.99 (m, 2 H), 3.9−3.87 (m, 2 H), 3.8 (s, 3 H), 2.64−2.62 (m, 2 H).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(5′-Fluoro-2′-methoxyphenyl)-1-ethylenedioxybutane (<b>6</b>)</h3><div class="NLM_p last">To a solution of <b>5</b> (1.75 g, 7.3 mmol, 1 equiv) in ethanol (200 proof, 80 mL) under an atmosphere of Ar was added Pd/C (10%, 300 mg, 0.1 equiv), and the flask containing the mixture was evacuated and purged with H<sub>2</sub> three times. H<sub>2</sub> gas was attached to the flask and the reaction was allowed to proceed for 72 h at room temperature. The reaction mixture was then filtered through a pad of celite and eluted with EtOH. The crude product was obtained by removal of the solvent in vacuo. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.87−6.72 (m, 3 H), 4.87 (t, <i>J</i> = 3.8 Hz, 1 H), 3.97−3.95 (m, 2 H), 3.86−3.83 (m, 2 H), 3.79 (s, 3 H), 2.64−2.62 (m, 2 H), 2.44 (td, <i>J</i> = 1.7, 7.2 Hz, 2 H), 1.92 (quintet, <i>J</i> = 7.5 Hz, 2 H).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(5′-Fluoro-2′-methoxyphenyl)butyraldehyde (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (1.7 g, 7.0 mmol, 1 equiv) in THF (60 mL) was added HCl (1 N, 3 mL), and the reaction was stirred at room temperature for 48 h. The reaction mixture was then poured into a separatory funnel containing water (60 mL). The organic fraction was extracted with EtOAc (3 × 60 mL), and the combined organic layers were washed with brine (80 mL) and dried over sodium sulfate. The crude product obtained by removal of the solvent in vacuo was purified by flash column chromatography (EtOAc/hexane, 10:90, v:v, <i>R</i><sub>f</sub> = 0.1) to give the product (1.03 g, 53% from <b>3a</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 9.76 (s, 1 H), 6.88−6.83 (m, 2 H), 6.75 (dd, <i>J</i> = 4.6, 8.6 Hz, 1 H), 3.79 (s, 3 H), 2.63 (t, <i>J</i> = 7.4 Hz, 2 H), 2.44 (t, <i>J</i> = 7.4 Hz, 2 H), 1.92 (quintet, <i>J</i> = 7.4 Hz, 2 H).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 7-(5′-Fluoro-2′-methoxyphenyl)hept-1-en-5-ol (<b>8</b>)</h3><div class="NLM_p">To a solution of <b>4</b> (3.0 g, 19.5 mmol, 1 equiv) in THF (20 mL) at 0 °C was added a solution 1-butenylmagnesium bromide (0.5 M in THF, 45 mL, 22.5 mmol, 1.1 equiv) dropwise for 15 min. The reaction mixture was poured into a solution of saturated ammonium chloride (80 mL) in a separatory funnel. The organic fraction was extracted with EtOAc (3 × 60 mL) and the combined organic layers were washed with brine (50 mL) and dried over sodium sulfate. The product was purified by flash column chromatography (EtOAc/hexane, 15:85, v:v, <i>R</i><sub>f</sub> = 0.2) to give the product as a colorless oil (3.7 g, 94%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.86−6.82 (m, 2 H), 6.76 (dd, <i>J</i> = 4.6, 8.6 Hz, 1 H), 5.82 (m, 1 H), 5.04 (d, <i>J</i> = 17.3 Hz, 1 H), 4.95 (d, <i>J</i> = 10.2 Hz, 1 H), 3.81 (s, 3 H), 3.55 (m, 1 H),2.75−2.69 (m, 2 H), 2.2 (m, 1 H), 2.1 (m, 1 H), 1.96 (bs, 1 H), 1.73−1.68 (m, 2 H), 1.6−1.53 (m, 3 H).</div><div class="NLM_p last">The following compound was prepared in a similar manner.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 8-(5′-Fluoro-2′-methoxyphenyl)oct-1-en-5-ol (<b>9</b>)</h3><div class="NLM_p last">The product was purified by flash column chromatography (EtOAc/hexane, 12.5:87.5, v:v, <i>R</i><sub>f</sub> = 0.15) as a colorless oil (1.06 g, 61%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.86−6.82 (m, 2 H), 6.74 (dd, <i>J</i> = 4.6, 8.6 Hz, 1 H), 5.85 (m, 1 H), 5.04 (d, <i>J</i> = 17.3 Hz, 1 H), 4.97 (d, <i>J</i> = 10.2 Hz, 1 H), 3.79 (s, 3 H), 3.66 (m, 1 H), 2.6 (m, 2 H), 2.22−2.1 (m, 2 H), 1.74−1.47 (m, 7 H).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-(Bromomethyl)-5-(2′-methoxy-5′-fluorophenethyl)tetrahydrafuran (<b>10</b>)</h3><div class="NLM_p">To a solution of <b>8</b> (3.24 g, 18.0 mmol, 1 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) at 0 °C was added <i>N</i>-bromosuccinimide (3.56 g, 20 mmol, 1.1 equiv) portionwise, and the reaction was warmed to room temperature and stirred for 12 h. Solvent was then removed in vacuo and the product was purified by flash column chromatography (EtOAc/hexane, 5:95, v:v, <i>R</i><sub>f</sub> = 0.1) and resulted in a colorless oil as a 2:1 mixture of <i>trans</i>/<i>cis</i> diastereomers. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.86−6.81 (m, 2 H), 6.72 (dd, <i>J</i> = 4.6, 8.6 Hz, 1 H), 4.22 (m, 1 H), 4.03 (m, 1 H), 3.78 (s, 3 H), 3.44 (dd, <i>J</i> = 4.3, 9.7 Hz, 1 H), 3.34 (dd, <i>J</i> = 6.4, 9.7 Hz, 1 H), 2.6 (t, <i>J</i> = 7.3 Hz, 2 H), 2.13 (m, 1 H), 2.05 (m, 1 H), 1.75 (m, 1 H), 1.67−1.46 (m, 5 H).</div><div class="NLM_p last">The following compound was prepared in a similar manner.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(Bromomethyl)-5-(3′-(2′′-methoxy-5′′-fluorophenyl)-1′-propyl)tetrahydrofuran (<b>11</b>)</h3><div class="NLM_p last">The product was purified by flash column chromatography (EtOAc/hexane, 5:95, v:v, <i>R</i><sub>f</sub> = 0.1) to provide a product (530 mg, 40%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.86−6.81 (m, 2 H), 6.72 (dd, <i>J</i> = 4.6, 8.6 Hz, 1 H), 4.22 (m, 1 H), 4.03 (m, 1 H), 3.78 (s, 3 H), 3.44 (dd, <i>J</i> = 4.3, 9.7 Hz, 1 H), 3.34 (dd, <i>J</i> = 6.4, 9.7 Hz, 1 H), 2.6 (t, <i>J</i> = 7.3 Hz, 2 H), 2.13 (m, 1 H), 2.05 (m, 1 H), 1.75 (m, 1 H), 1.67−1.46 (m, 5 H).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Cyanomethyl-5-(5′-fluoro-2-methoxyphenethyl)tetrahydrofuran (<b>12</b>)</h3><div class="NLM_p">To a vial under an atmosphere of Ar<sub>(g)</sub> was added <b>10</b> (1.23 g, 4.3 mmol, 1 equiv), NaI (100 mg, 1.3 mmol, 0.3 equiv), potassium cyanide (0.7 g, 10.6 mmol, 2.4 equiv), and dry DMSO (15 mL). The mixture obtained was heated to 70 °C under an atmosphere of Ar for 12 h. After cooling to room temperature, the reaction mixture was poured into a separatory funnel containing sodium bicarcarbonate aqueous solution (sat. NaHCO<sub>3</sub>/H<sub>2</sub>O, 50:50, v:v, 80 mL). The organic fraction was extracted with EtOAc (3 × 60 mL), and the combined organic layers were washed with brine (50 mL) and dried over sodium sulfate. The solvent was then removed in vacuo and the crude product obtained (0.45 g, 86%) was purified by flash column chromatography (EtOAc/hexane, 10:90, v:v, <i>R</i><sub>f</sub> = 0.11) as a 2:1 mixture of <i>trans</i>/<i>cis</i> diastereomers. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.88−6.82 (m, 2 H), 6.74 (dd, <i>J</i> = 4.3, 8.5 Hz, 1 H), 4.26 (m, 1 H), 4.09 (m, 0.65 H), 3.90 (m, 0.35 H)3.79 (s, 3 H), 2.72−2.53 (m, 4 H), 2.22−2.04 (m, 2 H), 1.84−1.6 (m, 4 H).</div><div class="NLM_p last">The following compound was prepared in a similar manner.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Cyanomethyl-5-(3′-(2′′-methoxy-5′′-fluorophenyl)-1′-propyl)tetrahydrafuran (<b>13</b>)</h3><div class="NLM_p last">The product (0.2 g, 80%) was purified by chromatography (EtOAc/hexane, 10:90, v:v, <i>R</i><sub>f</sub> = 0.11) to give a 2:1 mixture of <i>trans</i>/<i>cis</i> diastereomers. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 6.86−6.81 (m, 2 H), 6.73 (dd, <i>J</i> = 4.2, 8.5 Hz, 1 H), 4.22 (p, <i>J</i> = 6.8 Hz, 0.65 H), 4.11 (m, 0.35 H) 4.09 (m, 0.65 H), 3.9 (m, 0.35 H), 3.79 (s, 3 H), 2.62−2.52 (m, 4 H), 2.18 (m, 1 H), 2.12 (m, 1 H), 1.78 (m, 1 H), 1.69−1.46 (m, 3 H).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine (<b>14</b>)</h3><div class="NLM_p">To a round-bottom flask under an atmosphere of Ar was added Raney Ni (5 mg, 0.03 mmol, 0.1 equiv) that was washed with methanol. Compound <b>12</b> (80 mg, 0.3 mmol, 1 equiv), dissolved in 2 M NH<sub>3</sub> in methanol, was added to the flask. The flask was evacuated and purged with H<sub>2</sub> once. H<sub>2</sub> gas was then attached to the flask, and the reaction was allowed to stirr for 4 h at room temperature. The reaction mixture was filtered through a plug of celite and the crude product obtained after the removal of the solvent was purified by preparative TLC and eluted with (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 10:90, v:v, <i>R</i><sub>f</sub> = 0.1) to give the product (55 mg, 70%) as a 2:1 mixture of <i>trans</i>/<i>cis</i> diastereomers. <sup>1</sup>H NMR: (CDCl<sub>3</sub>, 500 MHz): δ 6.87 (m, 1 H), 6.82 (dd, <i>J</i> = 3.0, 8.5 Hz, 1 H), 6.72 (m, 1 H), 4.03 (m, 0.65 H), 3.96 (m, 0.65 H), 3.89 (m, 0.35 H), 3.82 (m, 0.35 H), 3.78 (s, 3 H), 2.68 (m, 1 H), 2.58 (m, 1 H), 2.03 (m, 2 H), 1.83 (bs, 2 H), 1.86−1.6 (m, 4 H), 1.54 (m, 2 H). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>23</sub>FNO<sub>2</sub> 268.1713, found 268.1701.</div><div class="NLM_p last">The following compound was prepared in a similar manner.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine (<b>15</b>)</h3><div class="NLM_p last">The product (24 mg, 47%), was isolated as 3:1 mixture of <i>trans</i>/<i>cis</i> diastereomers (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 10:90, v:v, <i>R</i><sub>f</sub> = 0.1). <sup>1</sup>H NMR: (CDCl<sub>3</sub>, 500 MHz): δ 6.86−6.8 (m, 2 H), 6.73 (m, 1 H), 4.02 (m, 0.65 H), 3.96 (m, 0.65 H), 3.92 (m, 0.35 H), 3.82 (m, 0.35 H), 3.78 (s, 3 H), 3.09 (m, 1 H), 2.99 (m, 1 H), 2.6 (bs, 2 H), 1.96 (m, 2 H), 1.83−1.77 (m, 2 H), 1.65−1.47 (m, 8 H). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>25</sub>FNO<sub>2</sub> 282.1875, found 282.1869.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3,4-Dimethoxyphenylmagnesium bromide (<b>17</b>)</h3><div class="NLM_p last">Into a flame-dried round-bottom flask with a magnetic stir bar was placed anhydrous THF (150 mL) and Mg<sub>(s)</sub> turnings (1.43 g, 58.8 mmol, 1.0 equiv). The flask was then fitted with a pressure equalizing addition funnel containing 4-bromo-1,2-dimethoxybenzene (8.2 g, 58.8 mmol, 1 equiv) (<b>16</b>) solution that was added slowly over a period of 45 min while stirring at rt. Once the addition was complete, I<sub>2(s)</sub> (500 mg) was added and the reaction was brought to reflux and stirred for 12 h. The Grignard reagent was cooled and used immediately in the following reaction.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-(3,4-Dimethoxy-benzoyl)-cyclohex-3-enecarboxylic acid (<b>18</b>)</h3><div class="NLM_p last">A solution of <b>17</b> (9.6 g, 59 mmol, 0.29 M, 1 equiv) in THF was added dropwise to an ice-cooled solution of <i>cis</i>-1,2,3,6-tetrahydrophthalic anhydride (8.9 g, 59 mmol, 1 equiv) in THF (120 mL) over a 1 h period. After the addition was complete, the resulting mixture was stirred for another 30 min at 0 °C. The reaction mixture was allowed to warm to rt and stirred overnight. The reaction was then stopped with sat. NH<sub>4</sub>Cl and the pH adjusted to 2 with concentrated HCl<sub>(aq)</sub> and extracted with diethyl ether. The organic layer was washed with water and subsequently extracted with 1 M NaOH. The combined aqueous extract was acidified with concentrated HCl and extracted with EtOAc (3 × 100 mL). The organic layers were combined and dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford oil. The oil was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and filtered through silica gel to remove the dicarboxylic acid formed during workup. The product was recrystallized from diethyl ether to afford pure product (1.62 g, 10%) as a white solid; mp = 109 °C. LRMS ESI [M − H]<sup>−</sup> calcd for C<sub>16</sub>H<sub>18</sub>O<sub>5</sub> 289, found <i>m</i>/<i>z</i> 289. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 7.60−7.53 (m, 2 H), 6.92 (d, <i>J</i> = 8.4 Hz, 1 H), 5.84−5.82 (m, 1 H), 5.71−5.68 (m, 1 H), 4.03−4.00 (m, 1 H), 3.98 (s, 3 H), 3.95 (s, 1 H), 3.10−3.07 (m, 1 H), 2.90−2.84 (m, 1 H), 2.54−2.44 (m, 3 H).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(3,4-Dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>19</b>)</h3><div class="NLM_p last">A mixture of <b>18</b> (610 mg, 2.1 mmol, 1.0 equiv) and hydrazine hydrate (168 mg, 5.25 mmol, 2.5 equiv) in EtOH (10 mL) was refluxed for 4 h. The reaction was then cooled to rt and concentrated under reduced pressure to afford a white precipitate. The precipitate was dissolved in EtOAc and washed with Na<sub>2</sub>SO<sub>4(aq)</sub>, 1 N HCl<sub>(aq)</sub>, and water. The organic layer was then dried over MgSO<sub>4</sub>, filtered, and concentrated to give a white precipitate. The precipitate was recrystalized in EtOH to afford the product as white crystals (376 mg, 63%). HRMS ESI [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> 287.3385, found <i>m</i>/<i>z</i> 287.3379. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 8.53 (bs, 1 H), 7.46 (d, <i>J</i> = 2.0 Hz, 1 H), 7.23 (dd, <i>J</i> = 2.0, 8.4 Hz, 1 H), 6.87 (d, <i>J</i> = 8.4 Hz, 1 H), 5.8−5.77 (m, 1 H), 5.72−5.7 (m, 1 H), 3.94 (s, 3 H), 3.93 (s, 3 H), 3.4 (dt, <i>J</i> = 5.5, 8.7 Hz, 1 H), 3.01−2.97 (m, 1 H), 2.85 (t, <i>J</i> = 6.0 Hz, 1 H), 2.26−2.19 (m, 3 H). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> 287.3385, found 287.3376. HPLC > 98% pure (<i>t</i><sub>R</sub> = 4.93, 70(A):30(E); <i>t</i><sub>R</sub> = 5.33, 50(A):50(E)).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(5-Bromo-pentyl)-4-(3,4-dimethoxy-phenyl-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>20</b>)</h3><div class="NLM_p last">Sodium hydride (60% dispersion in oil, 44 mg, 1.1 mmol, 1.1 equiv) was added to a solution <b>19</b> (287 mg, 1.0 mmol, 1.0 equiv). The mixture was stirred at rt for 30 min, whereupon it took on a slight yellow color. 1,5-Dibromopentane (600 mg, 2.6 mmol, 2.6 eq) was added via syringe, and the reaction was stirred for 30 min at rt while the yellow color dissipated to an almost clear solution. The reaction was stopped with the addition of water and then transferred to a separatory funnel and extracted with Et<sub>2</sub>O (3 × 30 mL). The organic fractions were combined and dried over MgSO<sub>4</sub>, filtered, and concentrated to afford an oil. The product was purified on silica and eluted with CH<sub>2</sub>Cl<sub>2</sub> to afford a clear oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 7.47 (d, <i>J</i> = 2.0 Hz, 1 H), 7.25 (dd, <i>J</i> = 2.0, 8.5 Hz, 1 H), 6.87 (d, <i>J</i> = 8.5 Hz, 1 H), 5.8−5.77 (m, 1 H), 5.7−5.67 (m, 1 H), 4.01−3.97 (m, 1 H), 3.95 (s, 3 H), 3.92 (s, 3 H), 3.79−3.74 (m, 1 H), 2.22−2.18 (m, 2 H), 2.1−2.04 (m, 1 H), 1.94−1.86 (m, 4 H), 1.74−1.69 (m, 4 H), 1.63−1.56 (m, 1 H), 1.52−1.46 (m, 2 H). LRMS ESI [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>28</sub>BrN<sub>2</sub>O<sub>3</sub> 436, found <i>m</i>/<i>z</i> 435 (Br<sup>79</sup>), 437 (Br<sup>81</sup>). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>28</sub>BrN<sub>2</sub>O<sub>3</sub> 436.8007, found 436.8025.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl]-4,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>21</b>)</h3><div class="NLM_p">Into a flame-dried round-bottom flask under an atmosphere of Ar<sub>(g)</sub>, cesium hydroxide monohydrate (23 mg, 0.14 mmol, 1.0 equiv) and DMF (0.5 mL) was stirred for 30 min at rt. Compound <b>14</b> (37 mg, 0.14 mmol, 1.0 equiv) in DMF (0.3 mL) was then added via syringe and the resulting mixture was stirred at rt. After stirring an additional 30 min, compound <b>20</b> (72 mg, 0.16 mmol, 1.2 eq) dissolved in DMF (0.3 mL) was added and stirred for an additional 18 h at rt. The mixture was washed with EtOAc (30 mL) and then filtered, and the filtrate was washed with water in a separatory funnel. The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to oil. The product was purified by preparative TLC (developed with MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 5:95, v:v, <i>R</i><sub>f</sub> = 0.2) to afford an oil (27 mg, 0.04 mmol, 31%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.47 (d, <i>J</i> = 2.0 Hz, 1 H), 7.25 (dd, <i>J</i> = 2.0, 8.5 Hz, 1 H), 6.87 (d, <i>J</i> = 8.5 Hz, 1 H), 6.86−6.81 (m, 2 H), 6.76−6.72 (m, 1 H), 5.81−5.79 (m, 1 H), 5.71 (m, 1 H), 4.01−3.97 (m, 1 H), 3.94 (s, 3 H), 3.91 (s, 3 H), 3.8 (s, 3 H), 3.79−3.74 (m, 1 H), 3.36−3.31 (m, 1 H), 3.03−3.0 (m, 1 H), 2.81−2.78 (m, 2 H), 2.73−2.37 (m, 5 H), 2.30−2.19 (m, 3 H), 2.09−1.97 (m, 3 H), 1.87−1.26 (m, 14 H). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>36</sub>H<sub>49</sub>FN<sub>3</sub>O<sub>5</sub> 622.8007, found 622.8025.</div><div class="NLM_p last">The following compound was prepared in a similar manner.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl-4a,5,8,8a-tetrahydro-2<i>H</i>-phthalazin-1-one (<b>22</b>)</h3><div class="NLM_p last">The product was isolated by preparative TLC and (developed with MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 5:95, v:v, <i>R</i><sub>f</sub> = 0.2). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.47 (d, <i>J</i> = 2.0 Hz, 1 H), 7.25 (dd, <i>J</i> = 2.0, 8.5 Hz, 1 H), 6.87 (d, <i>J</i> = 8.5 Hz, 1 H), 6.86−6.81 (m, 2 H), 6.76−6.72 (m, 1 H), 5.8−5.77 (m, 1 H), 5.69−5.66 (m, 1 H), 4.01−3.97 (m, 1 H), 3.94 (s, 3 H), 3.91 (s, 3 H), 3.77 (s, 3 H), 3.79−3.74 (m, 1 H), 3.33−3.3 (m, 1 H), 3.0−2.96 (m, 1 H), 2.81−2.57 (m, 7 H), 2.22−2.17 (m, 3 H), 2.04−1.34 (m, 19 H). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>37</sub>H<sub>51</sub>FN<sub>3</sub>O<sub>5</sub> 636.8275, found 636.826.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-carbamic Ethyl Ester (<b>23</b>)</h3><div class="NLM_p last">Into a flame-dried 20 mL vial was placed K<sub>2</sub>CO<sub>3</sub> (239 mg, 1.73 mmol, 6.0 equiv) and anhydrous THF (5.0 mL). The vial was purged with Ar<sub>(g)</sub> and then cooled in an ice bath. Ethyl chloroformate (156 mg, 1.44 mmol, 5.0 equiv) was then added via syringe followed by slow addition of <b>14</b> (77 mg, 0.29 mmol, 1.0 equiv) dissolved in THF (1.5 mL). The reaction was stirred at 0 °C for 0.5 h and then warmed to rt and allowed to stir an additional 3 h. The reaction was then stopped with sat. NaHCO<sub>3(aq)</sub> and extracted with EtOAc (3 × 20 mL). The organic layer was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield crude product that was used in the next step of the synthesis. TLC: MeOH/CH<sub>2</sub>Cl<sub>2</sub> (2:98, v:v), <i>R</i><sub>f</sub> 0.4. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) 6.87−6.82 (m, 2 H), 6.74−6.71 (m, 1 H), 4.12 (q, <i>J</i> = 7.1 Hz, 2 H), 4.05−3.77 (m, 2 H), 3.78 (s, 3 H), 2.71−2.56 (m, 2 H), 2.08−1.51 (m, 10 H) 1.3 (t, <i>J</i> = 7.2 Hz, 3 H). LRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>27</sub>FNO<sub>4</sub> 340, found 340.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-ethyl]-tetrahydro-furan-2-yl}-ethylamine)-methyl-amine (<b>24</b>)</h3><div class="NLM_p last">Into a flame-dried round-bottom flask, purged with Ar<sub>(g)</sub>, was placed <b>23</b> (112 mg, 0.33 mmol, 1.0 equiv) and anhydrous THF (1.6 mL). The flask was cooled with an ice bath and stirred for 15 min. LAH (1.0 M, 1.32 mL, 1.32 mmol, 4.0 equiv) was then slowly added via a syringe over a period of 5 min. The reaction was allowed to warm to rt and stirred an additional 4 h. The reaction was then stopped with ice-cold MeOH and then stirred for an additional 15 min at rt. The resulting solution was acidified with 1 N HCl<sub>(aq)</sub> and then transferred to a beaker and then made basic with 10 M NaOH<sub>(aq).</sub> The basic solution was extracted with diethyl ether (3 × 20 mL), and then the organic layer was washed with brine. The diethyl ether extract was dried over Mg<sub>2</sub>SO<sub>4</sub> for 15 min and then filtered and concentrated to oil under reduced pressure to afford the crude product. The oil was purified with preparative TLC (developed with MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 5:95, v:v, <i>R</i><sub>f</sub> 0.05). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) 6.87−6.82 (m, 2 H), 6.74−6.71 (m, 1 H), 4.05−3.77 (m, 2 H), 3.78 (s, 3 H), 2.71−2.56 (m, 5 H), 2.08−1.51 (m, 10 H). HRMS (ESI) [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>25</sub>FNO<sub>2</sub> 282.3784, found 282.3762.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/jm8010993">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Analytical data of the target compounds is provided in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. This information is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8010993/suppl_file/jm8010993_si_001.pdf">jm8010993_si_001.pdf (35.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8010993" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John R. Cashman</span> - <span class="hlFld-Affiliation affiliation">Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, California 92121, West Virginia University Health Sciences Center, Morgantown, West Virginia 26505</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a0cac3c1d3c8cdc1cee0c8c2d2c98ecfd2c7"><span class="__cf_email__" data-cfemail="e8828b899b80858986a8808a9a81c6879a8f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy Voelker</span> - <span class="hlFld-Affiliation affiliation">Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, California 92121, West Virginia University Health Sciences Center, Morgantown, West Virginia 26505</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Han-Ting Zhang</span> - <span class="hlFld-Affiliation affiliation">Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, California 92121, West Virginia University Health Sciences Center, Morgantown, West Virginia 26505</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James M. O’Donnell</span> - <span class="hlFld-Affiliation affiliation">Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, California 92121, West Virginia University Health Sciences Center, Morgantown, West Virginia 26505</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are indebted to Professor Marco Conti (Stanford University) for providing the results shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. We also thank Dr. Aaron Janowsky and Robert Johnson (Portland VA Hospital, Portland, OR) for doing the binding and reuptake inhibition assays shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The work was supported in part by research grants and an Independent Scientist Award from the National Institute of Mental Health (J.O.D.).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Warner Schmidt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment</span> <span class="citation_source-journal">Hippocampus</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=239-249&author=J.+L.+Warner+Schmidtauthor=R.+S.+Duman&title=Hippocampal+neurogenesis%3A+opposing+effects+of+stress+and+antidepressant+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%2BSchmidt%26aufirst%3DJ.%2BL.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DHippocampal%2520neurogenesis%253A%2520opposing%2520effects%2520of%2520stress%2520and%2520antidepressant%2520treatment%26jtitle%3DHippocampus%26date%3D2006%26volume%3D16%26spage%3D239%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Preskorn, S. H.; Stanga, C. Y.; Ross, R.</span><span> </span><span class="NLM_article-title">Selective Serotonin Reuptake Inhibitor</span>. In  <span class="citation_source-book">Antidepressants: Past, Present, and Future</span>; <span class="NLM_contrib-group">Preskorn, S. H.; Stanga, C. Y.; Feighner, J. P.; Ross, R.</span>, Eds.; <span class="NLM_publisher-name">Springer Publishing Co.</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">242</span>− <span class="NLM_lpage">264</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=242-264&author=S.+H.+Preskorn&author=C.+Y.+Stanga&author=R.+Rossauthor=S.+H.+Preskorn&author=C.+Y.+Stanga&author=J.+P.+Feighner&author=R.+Ross&title=Antidepressants%3A+Past%2C+Present%2C+and+Future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26atitle%3DSelective%2520Serotonin%2520Reuptake%2520Inhibitor%26btitle%3DAntidepressants%253A%2520Past%252C%2520Present%252C%2520and%2520Future%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26pub%3DSpringer%2520Publishing%2520Co%26date%3D2004%26spage%3D242%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horng, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, B. B.</span><span> </span><span class="NLM_article-title">A new selective inhibitor for uptake of serotonin into synaptosomes or rat brain: 3-(<i>p</i>-trifluoromethylphenoxy)-<i>N</i>-methyl-3-phenylpropylamine (Lilly 110140)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1975</span> <span class="NLM_volume">193</span> <span class="NLM_fpage">804</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=1151730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaE2MXkslajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1975&pages=804-811&author=D.+T.+Wongauthor=F.+P.+Bymasterauthor=J.+S.+Horngauthor=B.+B.+Molloy&title=A+new+selective+inhibitor+for+uptake+of+serotonin+into+synaptosomes+or+rat+brain%3A+3-%28p-trifluoromethylphenoxy%29-N-methyl-3-phenylpropylamine+%28Lilly+110140%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New selective inhibitor for uptake of serotonin into synaptosomes of rat brain.  3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine</span></div><div class="casAuthors">Wong, David T.; Bymaster, Frank P.; Horng, Jong S.; Molloy, Bryan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">804-11</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Lilly 110140 (3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine) [54910-89-3] competitively inhibited the uptake of serotonin (5-HT) [50-67-9], norepinephrine (NE) [51-41-2] and dopamine [51-61-6] into synaptosomes of rat brain with Ki values of 5.5 × 10-8, 9.5 × 10-6 and 1.3 × 10-5 M, resp.  The trifluoromethyl group in the phenoxy ring was most favorable at the para-position and was better than other substituting groups including fluoro, chloro, methyl and methoxy groups.  The N-demethylated (primary amine) and the N,N-dimethylated (tertiary amine) derivs. inhibited the uptake of monoamines with the same effectiveness as Lilly 110140 (a secondary amine).  The uptake of 5-HT into synaptosomes was significantly inhibited 15 min after an intraperitoneal administration of Lilly 110140.  The inhibition persisted for a 24-hr period.  NE uptake in vitro maintained a normal rate during the entire time course.  Lilly 110140 likewise had no effect on the in vitro and in vivo accumulation of 3H-tryptophan in the brain.  The effects of Lilly 110140 and the tricyclic drug, chlorimipramine [303-49-1], were compared.  Although chlorimipramine inhibited the uptake of 5-HT into synaptosomes with same effectiveness as Lilly 110140 in vitro, it reduced the uptake of both 5-HT and NE in vivo.  Chlorimipramine exerted its greatest inhibition on the two uptake processes in the 1st hr and none by the 4th hr.  Unlike the tricyclic drugs, imipramine [50-49-7], chlorimipramine, desipramine [50-47-5] and chlordesipramine [303-48-0].  Lilly 110140 and its primary amine deriv. did not block the in vivo uptake of NE into rat heart.  Thus, Lilly 110140 is a potent and selective inhibitor for uptake of 5-HT into synaptosomes of rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDMsudrbujErVg90H21EOLACvtfcHk0ljM_ivht5BICA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXkslajs7Y%253D&md5=8a7cd03e92be9f3319eb9d3c6aed498d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DHorng%26aufirst%3DJ.%2BS.%26aulast%3DMolloy%26aufirst%3DB.%2BB.%26atitle%3DA%2520new%2520selective%2520inhibitor%2520for%2520uptake%2520of%2520serotonin%2520into%2520synaptosomes%2520or%2520rat%2520brain%253A%25203-%2528p-trifluoromethylphenoxy%2529-N-methyl-3-phenylpropylamine%2520%2528Lilly%2520110140%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1975%26volume%3D193%26spage%3D804%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, E. A.</span><span> </span><span class="NLM_article-title">Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug (in US): twenty years since its first publication</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">411</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=411-441&author=D.+T.+Wongauthor=F.+P.+Bymasterauthor=E.+A.+Engleman&title=Prozac+%28fluoxetine%2C+Lilly+110140%29%2C+the+first+selective+serotonin+uptake+inhibitor+and+an+antidepressant+drug+%28in+US%29%3A+twenty+years+since+its+first+publication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DEngleman%26aufirst%3DE.%2BA.%26atitle%3DProzac%2520%2528fluoxetine%252C%2520Lilly%2520110140%2529%252C%2520the%2520first%2520selective%2520serotonin%2520uptake%2520inhibitor%2520and%2520an%2520antidepressant%2520drug%2520%2528in%2520US%2529%253A%2520twenty%2520years%2520since%2520its%2520first%2520publication%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D57%26spage%3D411%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span> </span><span class="NLM_article-title">Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">1053</span> <span class="NLM_fpage">54</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1016%2Fj.brainres.2005.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=16040010" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1053&publication_year=2005&pages=54-61&author=K.+Hiranoauthor=T.+Sekiauthor=N.+Sakaiauthor=Y.+Katoauthor=H.+Hashimotoauthor=S.+Uchidaauthor=S.+Yamada&title=Effects+of+continuous+administration+of+paroxetine+on+ligand+binding+site+and+expression+of+serotonin+transporter+protein+in+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DUchida%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26atitle%3DEffects%2520of%2520continuous%2520administration%2520of%2520paroxetine%2520on%2520ligand%2520binding%2520site%2520and%2520expression%2520of%2520serotonin%2520transporter%2520protein%2520in%2520mouse%2520brain%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1053%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span> </span><span class="NLM_article-title">The discovery of fluoxetine hydrochloride (Prozac)</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">764</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1038%2Fnrd1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=16121130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslaqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=764-774&author=D.+T.+Wongauthor=K.+W.+Perryauthor=F.+P.+Bymaster&title=The+discovery+of+fluoxetine+hydrochloride+%28Prozac%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Case History: The Discovery of Fluoxetine Hydrochloride (Prozac)</span></div><div class="casAuthors">Wong, David T.; Perry, Kenneth W.; Bymaster, Frank P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the early 1970s, evidence of the role of serotonin (5-hydroxytryptamine or 5-HT) in depression began to emerge and the hypothesis that enhancing 5-HT neurotransmission would be a viable mechanism to mediate antidepressant response was put forward.  On the basis of this hypothesis, efforts to develop agents that inhibit the uptake of 5-HT from the synaptic cleft were initiated.  These studies led to the discovery and development of the selective serotonin-reuptake inhibitor fluoxetine hydrochloride (Prozac; Eli Lilly), which was approved for the treatment of depression by the US FDA in 1987.  Here, we summarize this research and discuss the many challenges that we encountered during the development of fluoxetine hydrochloride, which has now been widely acknowledged as a breakthrough drug for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsQ0Uof9mDk7Vg90H21EOLACvtfcHk0ljHBM07-xaQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslaqsL8%253D&md5=9e85885a209317fb10670af0de851978</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1821%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26atitle%3DThe%2520discovery%2520of%2520fluoxetine%2520hydrochloride%2520%2528Prozac%2529%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D764%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haneda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span> </span><span class="NLM_article-title">Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">28</span> <span class="NLM_fpage">6272</span> <span class="NLM_lpage">6280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1523%2FJNEUROSCI.1656-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=18550770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ynsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=6272-6280&author=K.+Kobayashiauthor=Y.+Ikedaauthor=E.+Hanedaauthor=H.+Suzuki&title=Chronic+fluoxetine+bidirectionally+modulates+potentiating+effects+of+serotonin+on+the+hippocampal+mossy+fiber+synaptic+transmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission</span></div><div class="casAuthors">Kobayashi, Katsunori; Ikeda, Yumiko; Haneda, Eisuke; Suzuki, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6272-6280</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Selective serotonin reuptake inhibitors (SSRIs) have been used to treat various psychiatric disorders.  Although the cellular mechanisms underlying amelioration of particular symptoms are mostly unknown, recent studies have shown crit. importance of the dentate gyrus of the hippocampus in behavioral effects of SSRIs in rodents.  Here, we show that serotonin potentiates synaptic transmission between mossy fibers, the sole output of the dentate granule cells, and CA3 pyramidal cells in mouse hippocampal slices.  This potentiation is mediated by activation of 5-HT4 receptors and intracellular cAMP elevation.  A chronic treatment of mice with fluoxetine, a widely used SSRI, bidirectionally modulates the 5-HT-induced potentiation: Fluoxetine enhances the potentiation induced by lower concns. of serotonin, while attenuates that by the higher concn., which represents stabilization of synaptic 5-HT action.  In contrast to the chronic treatment, an acute application of fluoxetine in slices induces a leftward shift in the dose-response curve of the 5-HT-induced potentiation.  Thus, acute and chronic fluoxetine treatments have distinct effects on the serotonergic modulation of the mossy fiber synaptic transmission.  Exposure of mice to novel environments induces increases in locomotor activity and hippocampal extracellular 5-HT levels.  In mice chronically treated with fluoxetine, the novelty-induced hyperactivity is reduced without significant alterations in home cage activity and motor skills.  Our results suggest that the chronic fluoxetine treatment can stabilize the serotonergic modulation of the central synaptic transmission, which may contribute to attenuation of hyperactive behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpraz4UOv7VNrVg90H21EOLACvtfcHk0ljHBM07-xaQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ynsrY%253D&md5=15f5ce241a0843d3382c747a04fc589b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1656-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1656-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DHaneda%26aufirst%3DE.%26aulast%3DSuzuki%26aufirst%3DH.%26atitle%3DChronic%2520fluoxetine%2520bidirectionally%2520modulates%2520potentiating%2520effects%2520of%2520serotonin%2520on%2520the%2520hippocampal%2520mossy%2520fiber%2520synaptic%2520transmission%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D6272%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">74</span> <span class="NLM_fpage">1257</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=10693959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlChtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=1257-1262&author=Y.+Yeauthor=K.+Jacksonauthor=J.+M.+O%E2%80%99Donnell&title=Effects+of+repeated+antidepressant+treatment+of+type+4A+phosphodiesterase+%28PDE4A%29+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of repeated antidepressant treatment on type 4A phosphodiesterase (PDE4A) in rat brain</span></div><div class="casAuthors">Ye, Ying; Jackson, Keasha; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1257-1262</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In a previous study, an up-regulation of rolipram-sensitive, low-Km, cAMP phosphodiesterase (PDE4) subtype PDE4A in rat cerebral cortex following repeated treatment of desipramine was obsd.  To det. whether this effect is shared by antidepressants from different pharmacol. classes, PDE4A expression was examd. using immunoblot analyses following repeated treatment with the norepinephrine reuptake inhibitor desipramine, the monoamine oxidase inhibitor phenelzine, the atypical antidepressant trazodone, and the serotonin reuptake inhibitor fluoxetine.  Desipramine, phenelzine, and fluoxetine all increased the intensities of the PDE4A bands in hippocampal prepns.; trazodone did not.  In prepns. of cerebral cortex, the intensities of the PDE4A bands were increased following desipramine treatment, not changed following phenelzine or fluoxetine treatment, and decreased following trazodone treatment.  It appears that repeated treatment with antidepressant drugs from different pharmacol. classes produces similar effects on the expressions of PDE4A variants in hippocampus.  This effect is not correlated with the changes in β-adrenergic receptor densities, suggesting these antidepressants may at some point alter intracellular signal transduction pathways in a similar manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKr_pKyZ-rmLVg90H21EOLACvtfcHk0ljHBM07-xaQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlChtro%253D&md5=98053d9a02a290cbd923b0ae13bac3c5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DEffects%2520of%2520repeated%2520antidepressant%2520treatment%2520of%2520type%25204A%2520phosphodiesterase%2520%2528PDE4A%2529%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D1257%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Halene, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">PDE inhibitors in psychiatry—future options for dementia, depression and schizophrenia</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">870</span> <span class="NLM_lpage">878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=870-878&author=T.+B.+Haleneauthor=S.+J.+Siegel&title=PDE+inhibitors+in+psychiatry%E2%80%94future+options+for+dementia%2C+depression+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalene%26aufirst%3DT.%2BB.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DPDE%2520inhibitors%2520in%2520psychiatry%25E2%2580%2594future%2520options%2520for%2520dementia%252C%2520depression%2520and%2520schizophrenia%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D870%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Houslay, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span> </span><span class="NLM_article-title">Keynote review: phosphodiesterase-4 as a therapeutic target</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">1503</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1016%2FS1359-6446%2805%2903622-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=16257373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1503-1519&author=M.+D.+Houslayauthor=P.+Shaferauthor=K.+Y.+Zhang&title=Keynote+review%3A+phosphodiesterase-4+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-4 as a therapeutic target</span></div><div class="casAuthors">Houslay, Miles D.; Schafer, Peter; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1503-1519</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase-4 selective inhibitors have therapeutic potential for treating major diseases such as asthma and COPD, as well as depression, Parkinson's disease and Alzheimer's disease.  CAMP is a key second messenger in all cells.  It is compartmentalized within cells and its levels are controlled, as a result of spatially discrete signaling cassettes controlling its generation, detection and degrdn.  Underpinning compartmentalized cAMP signaling are ∼20 members of the phosphodiesterase-4 (PDE4) family.  The selective inhibition of this family generates profound, functional effects and PDE4 inhibitors are currently under development to provide potential, novel therapeutics for the treatment of inflammatory diseases, such as asthma, chronic obstructive pulmonary disease and psoriasis, as well as treating depression and serving as cognitive enhancers.  Here, we delineate the range of PDE4 isoforms, their role in signaling, their structural biol. and related preclin. and clin. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOabrPCOweLVg90H21EOLACvtfcHk0ljHBM07-xaQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrzL&md5=7c75a76543b75145a44ae8f4a2f3b2ac</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903622-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903622-6%26sid%3Dliteratum%253Aachs%26aulast%3DHouslay%26aufirst%3DM.%2BD.%26aulast%3DShafer%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26atitle%3DKeynote%2520review%253A%2520phosphodiesterase-4%2520as%2520a%2520therapeutic%2520target%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1503%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Diminished noradrenergic activity in the brain down-regulates Type 4 phosphodiesterase in rat cerebral cortex</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">1894</span> <span class="NLM_lpage">1902</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=8780016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK28XisVSku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=1894-1902&author=Y.+Yeauthor=J.+M.+O%E2%80%99Donnell&title=Diminished+noradrenergic+activity+in+the+brain+down-regulates+Type+4+phosphodiesterase+in+rat+cerebral+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex</span></div><div class="casAuthors">Ye, Ying; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1894-902</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">The present study examd. the in vivo regulation of rolipram-sensitive, high-affinity cAMP phosphodiesterase (PDE4) in rat cerebral cortex.  The hydrolysis of cAMP, formed by stimulation of β-adrenergic receptors, was measured in cerebral cortical slices.  Hydrolysis of cAMP formed under these conditions was inhibited by the PDE4-selective inhibitor rolipram but not by selective inhibitors of other PDE families.  Intraventricular infusion of 6-hydroxydopamine (6-OHDA; 200 μg) decreased the rate const. of cAMP hydrolysis and increased the cAMP half-life 17 days, but not 1 or 7 days, following the treatment.  A redn. in norepinephrine (NE) content occurred first; the NE level was reduced to 42, 24, and 6% of control at 1, 7 and 17 days after 6-OHDA infusion, resp.  This was followed by the development of supersensitivity of β-adrenergic receptor-linked adenylyl cyclase, which occurred 7 days after the infusion.  The redn. in PDE4 activity occurred last.  When a higher dose of 6-OHDA (300 μg) was used, the redn. in the rate const. of cAMP hydrolysis occurred by 7 days; at this time NE content was depleted to 6% of control.  Similar to 6-OHDA treatment, continuous blockade of β-adrenergic receptors, produced by chronic propranolol infusion, decreased the rate const. of cAMP hydrolysis.  Therefore, the current results indicate that diminished stimulation of β-adrenergic receptors, either by loss of noradrenergic innervation or by receptor blockade, reduces the activity of PDE4.  This suggests that PDE4 regulation may contribute in the homeostasis of the noradrenergic receptor-effector system in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5RpaxKfxvX7Vg90H21EOLACvtfcHk0ljWUEABNdMuow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVSku70%253D&md5=10e4bd31d8d82658542084f89bb64d10</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DDiminished%2520noradrenergic%2520activity%2520in%2520the%2520brain%2520down-regulates%2520Type%25204%2520phosphodiesterase%2520in%2520rat%2520cerebral%2520cortex%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D66%26spage%3D1894%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wachtel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, H. H.</span><span> </span><span class="NLM_article-title">Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_year" style="font-weight: bold;">1986</span> <span class="NLM_volume">25</span> <span class="NLM_fpage">1119</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=1119-1126&author=H.+Wachtelauthor=H.+H.+Schneider&title=Rolipram%2C+a+novel+antidepressant+drug%2C+reverses+the+hypothermia+and+hypokinesia+of+monoamine-depleted+mice+by+an+action+beyond+postsynaptic+monoamine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWachtel%26aufirst%3DH.%26aulast%3DSchneider%26aufirst%3DH.%2BH.%26atitle%3DRolipram%252C%2520a%2520novel%2520antidepressant%2520drug%252C%2520reverses%2520the%2520hypothermia%2520and%2520hypokinesia%2520of%2520monoamine-depleted%2520mice%2520by%2520an%2520action%2520beyond%2520postsynaptic%2520monoamine%2520receptors%26jtitle%3DNeuropharmacology%26date%3D1986%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zhang, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frith, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suvarna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">587</span> <span class="NLM_lpage">595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=587-595&author=H.+T.+Zhangauthor=Y.+Huangauthor=S.+L.+C.+Jinauthor=S.+A.+Frithauthor=N.+Suvarnaauthor=M.+Contiauthor=J.+M.+O%E2%80%99Donnell&title=Antidepressant-like+profile+and+reduced+sensitivity+to+rolipram+in+mice+deficient+in+the+PDE4D+phosphodiesterase+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DS.%2BL.%2BC.%26aulast%3DFrith%26aufirst%3DS.%2BA.%26aulast%3DSuvarna%26aufirst%3DN.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DAntidepressant-like%2520profile%2520and%2520reduced%2520sensitivity%2520to%2520rolipram%2520in%2520mice%2520deficient%2520in%2520the%2520PDE4D%2520phosphodiesterase%2520enzyme%26jtitle%3DNeuropsychopharmacology%26date%3D2002%26volume%3D27%26spage%3D587%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frith, S.</span><span> </span><span class="NLM_article-title">Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">63</span> <span class="NLM_fpage">185</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1999&pages=185-192&author=J.+M.+O%E2%80%99Donnellauthor=S.+Frith&title=Behavioral+effects+of+family-selective+inhibitors+of+cyclic+nucleotide+phosphodiesterases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26aulast%3DFrith%26aufirst%3DS.%26atitle%3DBehavioral%2520effects%2520of%2520family-selective%2520inhibitors%2520of%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D63%26spage%3D185%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokumura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span> </span><span class="NLM_article-title">Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">498</span> <span class="NLM_fpage">135</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1016%2Fj.ejphar.2004.07.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=15363987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFGks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2004&pages=135-142&author=T.+Itohauthor=M.+Tokumuraauthor=K.+Abe&title=Effects+of+rolipram%2C+a+phosphodiesterase+4+inhibitor%2C+in+combination+with+imipramine+on+depressive+behavior%2C+CRE-binding+activity+and+BDNF+level+in+learned+helplessness+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats</span></div><div class="casAuthors">Itoh, Tetsuji; Tokumura, Miwa; Abe, Kohji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">498</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">135-142</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The brain cAMP regulating system and its downstream elements play a pivotal role in the therapeutic effects of antidepressants.  We previously reported the increase in activities of phosphodiesterase 4, a major phosphodiesterase isoenzyme hydrolyzing cAMP, in the frontal cortex and hippocampus of learned helplessness rats, an animal model for depression.  The present study was undertaken to examine the combination of effects of rolipram, a phosphodiesterase 4 inhibitor, with imipramine, a typical tricyclic antidepressant, on depressive behavior in learned helplessness rats.  Concurrently, cAMP-response element (CRE)-binding activity and brain-derived neurotrophic factor (BDNF) levels related to the therapeutic effects of antidepressants were detd.  Repeated administration of imipramine (1.25 - 10 mg/kg, i.p.) or rolipram (1.25 mg/kg, i.p.) reduced the no. of escape failures in learned helplessness rats.  Imipramine could not completely ameliorate the escape behavior to a level similar to that of non-stressed rats even at 10 mg/kg.  However, repeated coadministration of rolipram with imipramine (1.25 and 2.5 mg/kg, resp.) almost completely eliminated the escape failures in learned helplessness rats.  The redn. of CRE-binding activities and BDNF levels in the frontal cortex or hippocampus in learned helplessness rats were ameliorated by treatment with imipramine or rolipram alone.  CRE-binding activities and/or BDNF levels of the frontal cortex and hippocampus were significantly increased by treatment with a combination of rolipram and imipramine compared to those in imipramine-treated rats.  These results indicated that coadministration of phosphodiesterase type 4 inhibitors with antidepressants may be more effective for depression therapy and suggest that elevation of the cAMP signal transduction pathway is involved in the antidepressive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWaiIQbR9XSbVg90H21EOLACvtfcHk0ljWUEABNdMuow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFGks7c%253D&md5=661db7d2594bf049a4780e7c5addfbd1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.07.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.07.084%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DTokumura%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DEffects%2520of%2520rolipram%252C%2520a%2520phosphodiesterase%25204%2520inhibitor%252C%2520in%2520combination%2520with%2520imipramine%2520on%2520depressive%2520behavior%252C%2520CRE-binding%2520activity%2520and%2520BDNF%2520level%2520in%2520learned%2520helplessness%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D498%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lourenco, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beanlands, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, J. N.</span><span> </span><span class="NLM_article-title">Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (<i>R</i>)-[<sup>11</sup>C]rolipram in rat brain, lung and heart</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">79</span> <span class="NLM_fpage">356</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=356-364&author=C.+M.+Lourencoauthor=M.+Kenkauthor=R.+S.+Beanlandsauthor=J.+N.+DaSilva&title=Increasing+synaptic+noradrenaline%2C+serotonin+and+histamine+enhances+in+vivo+binding+of+phosphodiesterase-4+inhibitor+%28R%29-%5B11C%5Drolipram+in+rat+brain%2C+lung+and+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DIncreasing%2520synaptic%2520noradrenaline%252C%2520serotonin%2520and%2520histamine%2520enhances%2520in%2520vivo%2520binding%2520of%2520phosphodiesterase-4%2520inhibitor%2520%2528R%2529-%255B11C%255Drolipram%2520in%2520rat%2520brain%252C%2520lung%2520and%2520heart%26jtitle%3DLife%2520Sci.%26date%3D2006%26volume%3D79%26spage%3D356%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Van der Mey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzelmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Klink, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Laan, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibaut, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span> </span><span class="NLM_article-title">Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted <i>cis</i>-tetra- and <i>cis</i>-hexahydrophthalazinones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">44</span> <span class="NLM_fpage">2523</span> <span class="NLM_lpage">2535</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010838c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2523-2535&author=M.+Van+der+Meyauthor=A.+Hatzelmannauthor=G.+P.+Van+Klinkauthor=I.+J.+Van+der+Laanauthor=G.+J.+Sterkauthor=U.+Thibautauthor=W.+R.+Ulrichauthor=H.+Timmerman&title=Novel+selective+PDE4+inhibitors.+2.+Synthesis+and+structure-activity+relationships+of+4-aryl-substituted+cis-tetra-+and+cis-hexahydrophthalazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm010838c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010838c%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BMey%26aufirst%3DM.%26aulast%3DHatzelmann%26aufirst%3DA.%26aulast%3DVan%2BKlink%26aufirst%3DG.%2BP.%26aulast%3DVan%2Bder%2BLaan%26aufirst%3DI.%2BJ.%26aulast%3DSterk%26aufirst%3DG.%2BJ.%26aulast%3DThibaut%26aufirst%3DU.%26aulast%3DUlrich%26aufirst%3DW.%2BR.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DNovel%2520selective%2520PDE4%2520inhibitors.%25202.%2520Synthesis%2520and%2520structure-activity%2520relationships%2520of%25204-aryl-substituted%2520cis-tetra-%2520and%2520cis-hexahydrophthalazinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2523%26epage%3D2535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Van der Mey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couwenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzelmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goubitz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span> </span><span class="NLM_article-title">Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration and PDE4 inhibitory activity of <i>cis</i>-tetra- and <i>cis</i>-hexahydrophthalazinones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">45</span> <span class="NLM_fpage">2526</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0110338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2526-2533&author=M.+Van+der+Meyauthor=H.+Bossauthor=D.+Couwenbergauthor=A.+Hatzelmannauthor=G.+J.+Sterkauthor=K.+Goubitzauthor=H.+Schenkauthor=H.+Timmerman&title=Novel+selective+phosphodiesterase+%28PDE4%29+inhibitors.+4.+Resolution%2C+absolute+configuration+and+PDE4+inhibitory+activity+of+cis-tetra-+and+cis-hexahydrophthalazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0110338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0110338%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BMey%26aufirst%3DM.%26aulast%3DBoss%26aufirst%3DH.%26aulast%3DCouwenberg%26aufirst%3DD.%26aulast%3DHatzelmann%26aufirst%3DA.%26aulast%3DSterk%26aufirst%3DG.%2BJ.%26aulast%3DGoubitz%26aufirst%3DK.%26aulast%3DSchenk%26aufirst%3DH.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DNovel%2520selective%2520phosphodiesterase%2520%2528PDE4%2529%2520inhibitors.%25204.%2520Resolution%252C%2520absolute%2520configuration%2520and%2520PDE4%2520inhibitory%2520activity%2520of%2520cis-tetra-%2520and%2520cis-hexahydrophthalazinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2526%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhar, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, J. L.</span><span> </span><span class="NLM_article-title">Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">6401</span> <span class="NLM_lpage">6409</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0401311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6401-6409&author=F.+I.+Carrollauthor=S.+P.+Runyonauthor=P.+Abrahamauthor=H.+Navarroauthor=M.+J.+Kuharauthor=G.+T.+Pollardauthor=J.+L.+Howard&title=Monoamine+transporter+binding%2C+locomotor+activity%2C+and+drug+discrimination+properties+of+3-%284-substituted-phenyl%29tropane-2-carboxylic+acid+methyl+ester+isomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0401311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0401311%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DNavarro%26aufirst%3DH.%26aulast%3DKuhar%26aufirst%3DM.%2BJ.%26aulast%3DPollard%26aufirst%3DG.%2BT.%26aulast%3DHoward%26aufirst%3DJ.%2BL.%26atitle%3DMonoamine%2520transporter%2520binding%252C%2520locomotor%2520activity%252C%2520and%2520drug%2520discrimination%2520properties%2520of%25203-%25284-substituted-phenyl%2529tropane-2-carboxylic%2520acid%2520methyl%2520ester%2520isomers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6401%26epage%3D6409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">289</span> <span class="NLM_fpage">877</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0liOi8wL9s4Mxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandrick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashman, J. R.</span><span> </span><span class="NLM_article-title">Synthesis of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">775</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=775-780&author=X.+Fengauthor=K.+Fandrickauthor=R.+Johnsonauthor=A.+Janowskyauthor=J.+R.+Cashman&title=Synthesis+of+3-carbomethoxy-4-%28aryl%29piperidines+and+in+vitro+and+in+vivo+pharmacological+evaluation%3A+identification+of+inhibitors+of+the+human+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DFandrick%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DCashman%26aufirst%3DJ.%2BR.%26atitle%3DSynthesis%2520of%25203-carbomethoxy-4-%2528aryl%2529piperidines%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520evaluation%253A%2520identification%2520of%2520inhibitors%2520of%2520the%2520human%2520dopamine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D775%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lucki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayorga, A. J.</span><span> </span><span class="NLM_article-title">Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">155</span> <span class="NLM_fpage">315</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2001&pages=315-322&author=I.+Luckiauthor=A.+Dalviauthor=A.+J.+Mayorga&title=Sensitivity+to+the+effects+of+pharmacologically+selective+antidepressants+in+different+strains+of+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26aulast%3DDalvi%26aufirst%3DA.%26aulast%3DMayorga%26aufirst%3DA.%2BJ.%26atitle%3DSensitivity%2520to%2520the%2520effects%2520of%2520pharmacologically%2520selective%2520antidepressants%2520in%2520different%2520strains%2520of%2520mice%26jtitle%3DPsychopharmacology%26date%3D2001%26volume%3D155%26spage%3D315%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">The forced swim test as a model for core and component behavioral effects of antidepressant drugs</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">523</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1097%2F00008877-199711000-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=9832966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFGju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=523-532&author=I.+Lucki&title=The+forced+swim+test+as+a+model+for+core+and+component+behavioral+effects+of+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The forced swimming test as a model for core and component behavioral effects of antidepressant drugs</span></div><div class="casAuthors">Lucki, I.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6&7</span>),
    <span class="NLM_cas:pages">523-532</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">A review with 58 refs.  The existence of a no. of classes of antidepressant drugs with diverse pharmacol. effects would lead one to expect that antidepressant drugs acting through different pharmacol. mechanisms should produce different behavioral effects.  Animal behavioral tests used to screen antidepressant drugs do not, however, discriminate between drugs that selectively enhance serotonin or norepinephrine transmission.  Several components of human depression are differently affected by drugs selectively interacting with either serotonin or norepinephrine transmission.  The ideal animal model for detecting antidepressant drug effects should thus be sensitive to all antidepressant drugs and should also display multiple components that are sensitive to specific drug classes.  The revised scoring of the forced swimming test corresponds to a behavioral test for antidepressant drugs that meet these criteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGYjC9W4JE8rVg90H21EOLACvtfcHk0liOi8wL9s4Mxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFGju7Y%253D&md5=695a23cc59f05189dcba632ed1cd5124</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2F00008877-199711000-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008877-199711000-00010%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DThe%2520forced%2520swim%2520test%2520as%2520a%2520model%2520for%2520core%2520and%2520component%2520behavioral%2520effects%2520of%2520antidepressant%2520drugs%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1997%26volume%3D8%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span> </span><span class="NLM_article-title">Characterization of a recombinant human dopamine transporter in multiple cell lines</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">274</span> <span class="NLM_fpage">276</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=7616409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK2MXntVWlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=276-283&author=A.+J.+Eshlemanauthor=R.+L.+Neveauthor=A.+Janowskyauthor=K.+A.+Neve&title=Characterization+of+a+recombinant+human+dopamine+transporter+in+multiple+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a recombinant human dopamine transporter in multiple cell lines</span></div><div class="casAuthors">Eshleman, Amy J.; Neve, Rachael L.; Janowsky, Aaron; Neve, Kim A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">276-83</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A 3.5-kilobase cDNA encoding the dopamine transporter was isolated from a human substantia nigra cDNA library.  Sequence anal. of the coding region of the transporter identified two nucleotide differences between the cDNA and published human dopamine transporter sequences.  One of the substitutions changed an amino acid conserved among previously cloned dopamine (DA) and norepinephrine transporters, Arg-344, to a methionine.  C6 glioma cells or COS-7 cells transfected with the cDNA (C6-hDAT and Cos7-hDAT cells) accumulated [3H]DA with high affinity (Km = 1.2 and 1.5 μM, resp.), and DA uptake inhibitors had similar potencies in both cell lines.  [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([3H]CFT) bound to membranes prepd. from both cell lines with high affinity (Kd = 2-6 nM), although some expts. with C6-hDAT cell membranes indicated the presence of a second class of binding sites with lower affinity for the radioligand.  Using the high-affinity Kd value for [3H]CFT binding detd. in Cos7-hDAT cells to calc. Ki values, drug affinity for inhibition was highly correlated (r = 0.92) with affinity for inhibition of [3H]DA uptake, although transporter substrates were significantly more potent inhibitors of uptake than of [3H]CFT binding.  The binding of [3H]1-[2-diphenylmethoxy]ethyl-4-(3-phenylpropyl)-piperazine ([3H]GBR-12935) to C6-hDAT cells could not be characterized due to high binding to untransfected C6 cells, but on Cos7-hDAT cells the radioligand labeled a single population of binding sites (Kd = 1 nM).  Inhibition of [3H]GBR-12935 binding by drugs correlated highly with inhibition of either [3H]CFT binding (r = 0.98) or of [3H]DA uptake (r = 0.95).  These results demonstrate that expression of an hDAT cDNA provides a binding site for both [3H]CFT and [3H]GBR-12935, and that the structural features of the human transporter that det. drug affinity for binding are similar to the structural features responsible for inhibition of [3H]DA uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_XowXERwrF7Vg90H21EOLACvtfcHk0liOi8wL9s4Mxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntVWlt7w%253D&md5=8b4986d7fbda5aa74a48693499318d48</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DNeve%26aufirst%3DR.%2BL.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26atitle%3DCharacterization%2520of%2520a%2520recombinant%2520human%2520dopamine%2520transporter%2520in%2520multiple%2520cell%2520lines%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D274%26spage%3D276%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umetsu, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, M.</span><span> </span><span class="NLM_article-title">Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">97</span> <span class="NLM_fpage">6751</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6751-6756&author=G.+Hansenauthor=S.+Jinauthor=D.+T.+Umetsuauthor=M.+Conti&title=Absence+of+muscarinic+cholinergic+airway+responses+in+mice+deficient+in+the+cyclic+nucleotide+phosphodiesterase+PDE4D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DUmetsu%26aufirst%3DD.%2BT.%26aulast%3DConti%26aufirst%3DM.%26atitle%3DAbsence%2520of%2520muscarinic%2520cholinergic%2520airway%2520responses%2520in%2520mice%2520deficient%2520in%2520the%2520cyclic%2520nucleotide%2520phosphodiesterase%2520PDE4D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D6751%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ting Peng, Baowen Qi, Jun He, Hengming Ke, <span class="NLM_string-name hlFld-ContribAuthor">Jianyou Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Development of Phosphodiesterase-4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10594-10617. <a href="https://doi.org/10.1021/acs.jmedchem.9b02170" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02170%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BPhosphodiesterase-4%252BInhibitors%26aulast%3DPeng%26aufirst%3DTing%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28122019%26date%3D10062020%26date%3D07042020%26volume%3D63%26issue%3D19%26spage%3D10594%26epage%3D10617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huan-Ming  Huang</span> and <span class="hlFld-ContribAuthor ">David J.  Procter</span>  . </span><span class="cited-content_cbyCitation_article-title">Dearomatizing Radical Cyclizations and Cyclization Cascades Triggered by Electron-Transfer Reduction of Amide-Type Carbonyls. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2017,</strong> <em>139 </em>
                                    (4)
                                     , 1661-1667. <a href="https://doi.org/10.1021/jacs.6b12077" title="DOI URL">https://doi.org/10.1021/jacs.6b12077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b12077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b12077%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDearomatizing%252BRadical%252BCyclizations%252Band%252BCyclization%252BCascades%252BTriggered%252Bby%252BElectron-Transfer%252BReduction%252Bof%252BAmide-Type%252BCarbonyls%26aulast%3DHuang%26aufirst%3DHuan-Ming%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23112016%26date%3D17012017%26date%3D01022017%26date%3D20122016%26volume%3D139%26issue%3D4%26spage%3D1661%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed Diwan M.  AbdulHameed</span>, <span class="hlFld-ContribAuthor ">Sidhartha  Chaudhury</span>, <span class="hlFld-ContribAuthor ">Narender  Singh</span>, <span class="hlFld-ContribAuthor ">Hongmao  Sun</span>, <span class="hlFld-ContribAuthor ">Anders  Wallqvist</span>, and <span class="hlFld-ContribAuthor ">Gregory J.  Tawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (2)
                                     , 492-505. <a href="https://doi.org/10.1021/ci2003544" title="DOI URL">https://doi.org/10.1021/ci2003544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci2003544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci2003544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExploring%252BPolypharmacology%252BUsing%252Ba%252BROCS-Based%252BTarget%252BFishing%252BApproach%26aulast%3DAbdulHameed%26aufirst%3DMohamed%2BDiwan%2BM.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D28072011%26date%3D23012012%26date%3D27022012%26date%3D24122011%26volume%3D52%26issue%3D2%26spage%3D492%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jigyansa ipsita  Pattnaik</span>, <span class="hlFld-ContribAuthor ">Deepthi R. A.</span>, <span class="hlFld-ContribAuthor ">Shivani  Dua</span>, <span class="hlFld-ContribAuthor ">Prasanta  Padhan</span>, <span class="hlFld-ContribAuthor ">Jayaprakash Russell  Ravan</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Tofisopam in Post COVID Neuro-psychiatric Sequelae: A Case Series. </span><span class="cited-content_cbyCitation_journal-name">Indian Journal of Psychological Medicine</span><span> <strong>2021,</strong> <em>43 </em>
                                    (2)
                                     , 174-176. <a href="https://doi.org/10.1177/0253717621994285" title="DOI URL">https://doi.org/10.1177/0253717621994285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0253717621994285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0253717621994285%26sid%3Dliteratum%253Aachs%26jtitle%3DIndian%2520Journal%2520of%2520Psychological%2520Medicine%26atitle%3DRole%252Bof%252BTofisopam%252Bin%252BPost%252BCOVID%252BNeuro-psychiatric%252BSequelae%25253A%252BA%252BCase%252BSeries%26aulast%3DPattnaik%26aufirst%3DJigyansa%2Bipsita%26date%3D2021%26date%3D2021%26volume%3D43%26issue%3D2%26spage%3D174%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika  Furlan</span>, <span class="hlFld-ContribAuthor ">Urban  Bren</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into Inhibitory Mechanism of PDE4D by Dietary Polyphenols Using Molecular Dynamics Simulations and Free Energy Calculations. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 479. <a href="https://doi.org/10.3390/biom11030479" title="DOI URL">https://doi.org/10.3390/biom11030479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11030479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11030479%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInsight%252Binto%252BInhibitory%252BMechanism%252Bof%252BPDE4D%252Bby%252BDietary%252BPolyphenols%252BUsing%252BMolecular%252BDynamics%252BSimulations%252Band%252BFree%252BEnergy%252BCalculations%26aulast%3DFurlan%26aufirst%3DVeronika%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zbigniew  Malinowski</span>, <span class="hlFld-ContribAuthor ">Emilia  Fornal</span>, <span class="hlFld-ContribAuthor ">Agata  Sumara</span>, <span class="hlFld-ContribAuthor ">Renata  Kontek</span>, <span class="hlFld-ContribAuthor ">Karol  Bukowski</span>, <span class="hlFld-ContribAuthor ">Beata  Pasternak</span>, <span class="hlFld-ContribAuthor ">Dariusz  Sroczyński</span>, <span class="hlFld-ContribAuthor ">Joachim  Kusz</span>, <span class="hlFld-ContribAuthor ">Magdalena  Małecka</span>, <span class="hlFld-ContribAuthor ">Monika  Nowak</span>. </span><span class="cited-content_cbyCitation_article-title">Amino- and polyaminophthalazin-1(2
              H
              )-ones: synthesis, coordination properties, and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>17 </em>, 558-568. <a href="https://doi.org/10.3762/bjoc.17.50" title="DOI URL">https://doi.org/10.3762/bjoc.17.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.17.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.17.50%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAmino-%252Band%252Bpolyaminophthalazin-1%2525282%252BH%252B%252529-ones%25253A%252Bsynthesis%25252C%252Bcoordination%252Bproperties%25252C%252Band%252Bbiological%252Bactivity%26aulast%3DMalinowski%26aufirst%3DZbigniew%26date%3D2021%26date%3D2021%26volume%3D17%26spage%3D558%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John L.  Krstenansky</span>. </span><span class="cited-content_cbyCitation_article-title">Mesembrine alkaloids: Review of their occurrence, chemistry, and pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2017,</strong> <em>195 </em>, 10-19. <a href="https://doi.org/10.1016/j.jep.2016.12.004" title="DOI URL">https://doi.org/10.1016/j.jep.2016.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2016.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2016.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DMesembrine%252Balkaloids%25253A%252BReview%252Bof%252Btheir%252Boccurrence%25252C%252Bchemistry%25252C%252Band%252Bpharmacology%26aulast%3DKrstenansky%26aufirst%3DJohn%2BL.%26date%3D2017%26volume%3D195%26spage%3D10%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Venkata Pavan  Kumar Kondapi</span>, <span class="hlFld-ContribAuthor ">Olivier-Mohamad  Soueidan</span>, <span class="hlFld-ContribAuthor ">Seyedeh Nargess  Hosseini</span>, <span class="hlFld-ContribAuthor ">Nauras  Jabari</span>, <span class="hlFld-ContribAuthor ">Frederick G.  West</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient and Easy Access to Optically Pure Tetrasubstituted Tetra­hydrofurans via Stereoselective Opening of
              C
              2
              -Symmetric Epoxide and Aziridine Rings. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (7)
                                     , 1367-1379. <a href="https://doi.org/10.1002/ejoc.201501540" title="DOI URL">https://doi.org/10.1002/ejoc.201501540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201501540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201501540%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEfficient%252Band%252BEasy%252BAccess%252Bto%252BOptically%252BPure%252BTetrasubstituted%252BTetra%2525C2%2525ADhydrofurans%252Bvia%252BStereoselective%252BOpening%252Bof%252BC%252B2%252B-Symmetric%252BEpoxide%252Band%252BAziridine%252BRings%26aulast%3DKumar%2BKondapi%26aufirst%3DVenkata%2BPavan%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D7%26spage%3D1367%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Sano</span>, <span class="hlFld-ContribAuthor ">Masanori  Kamura</span>, <span class="hlFld-ContribAuthor ">Akihito  Nakamura</span>, <span class="hlFld-ContribAuthor ">Syuji  Kitaike</span>, <span class="hlFld-ContribAuthor ">Michiyasu  Nakao</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of cis-4a,5,8,8a-Tetrahydrophthalazin-1(2H)-one Derivatives Based on Organocatalytic Alcoholysis of Cyclic Dicarboxylic Anhydride. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2016,</strong> <em>93 </em>
                                    (1)
                                     , 391. <a href="https://doi.org/10.3987/COM-15-S(T)17" title="DOI URL">https://doi.org/10.3987/COM-15-S(T)17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-15-S(T)17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-15-S%28T%2917%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DAsymmetric%252BSynthesis%252Bof%252Bcis-4a%25252C5%25252C8%25252C8a-Tetrahydrophthalazin-1%2525282H%252529-one%252BDerivatives%252BBased%252Bon%252BOrganocatalytic%252BAlcoholysis%252Bof%252BCyclic%252BDicarboxylic%252BAnhydride%26aulast%3DSano%26aufirst%3DShigeki%26date%3D2016%26volume%3D93%26issue%3D1%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noemí  Vila</span>, <span class="hlFld-ContribAuthor ">Pedro  Besada</span>, <span class="hlFld-ContribAuthor ">Tamara  Costas</span>, <span class="hlFld-ContribAuthor ">Mª Carmen  Costas-Lago</span>, <span class="hlFld-ContribAuthor ">Carmen  Terán</span>. </span><span class="cited-content_cbyCitation_article-title">Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 462-482. <a href="https://doi.org/10.1016/j.ejmech.2014.11.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhthalazin-1%2525282H%252529-one%252Bas%252Ba%252Bremarkable%252Bscaffold%252Bin%252Bdrug%252Bdiscovery%26aulast%3DVila%26aufirst%3DNoem%25C3%25AD%26date%3D2015%26volume%3D97%26spage%3D462%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Wenjun  Shan</span>, <span class="hlFld-ContribAuthor ">Qi  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiaxing  Xie</span>, <span class="hlFld-ContribAuthor ">Kefang  Lai</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 249-253. <a href="https://doi.org/10.1016/j.bmcl.2013.11.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.11.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.11.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bdual%252Bpharmacology%252B%2525CE%2525B22-adrenoceptor%252Bagonists%252Band%252BPDE4%252Binhibitors%26aulast%3DHuang%26aufirst%3DLing%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D249%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amadeu  Gavaldà</span>, <span class="hlFld-ContribAuthor ">Richard S  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase-4 inhibitors: a review of current developments (2010 – 2012). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (8)
                                     , 997-1016. <a href="https://doi.org/10.1517/13543776.2013.794789" title="DOI URL">https://doi.org/10.1517/13543776.2013.794789</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.794789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.794789%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPhosphodiesterase-4%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Bcurrent%252Bdevelopments%252B%2525282010%252B%2525E2%252580%252593%252B2012%252529%26aulast%3DGavald%25C3%25A0%26aufirst%3DAmadeu%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D8%26spage%3D997%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Gao</span>, <span class="hlFld-ContribAuthor ">Haojun  Gong</span>, <span class="hlFld-ContribAuthor ">Peng  Men</span>, <span class="hlFld-ContribAuthor ">Lu  Zhou</span>, <span class="hlFld-ContribAuthor ">Deyong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2013,</strong> <em>362 </em>, n/a-n/a. <a href="https://doi.org/10.1002/cjoc.201300079" title="DOI URL">https://doi.org/10.1002/cjoc.201300079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201300079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201300079%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BDual%252BInhibitors%252Bof%252BSecretory%252BPhospholipase%252BA2%252Band%252BSphingomyelin%252BSynthase%26aulast%3DGao%26aufirst%3DXing%26date%3D2013%26date%3D2013%26volume%3D362%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dietmar  Schomburg</span>, <span class="hlFld-ContribAuthor ">Ida  Schomburg</span>. </span><span class="cited-content_cbyCitation_article-title">3′,5′-cyclic-AMP phosphodiesterase 3.1.4.53. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 508-548. <a href="https://doi.org/10.1007/978-3-642-36240-8_114" title="DOI URL">https://doi.org/10.1007/978-3-642-36240-8_114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-36240-8_114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-36240-8_114%26sid%3Dliteratum%253Aachs%26atitle%3D3%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-cyclic-AMP%252Bphosphodiesterase%252B3.1.4.53%26aulast%3DSchomburg%26aufirst%3DDietmar%26date%3D2013%26spage%3D508%26epage%3D548%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DClass%252B2%2525E2%252580%2525933.2%252BTransferases%25252C%252BHydrolases%26aulast%3DSchomburg%26aufirst%3DDietmar%26date%3D2013%26volume%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Jun  Shan</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhou</span>, <span class="hlFld-ContribAuthor ">Huai-Lei  Jiang</span>, <span class="hlFld-ContribAuthor ">Zong-Hua  Luo</span>, <span class="hlFld-ContribAuthor ">Ke-fang  Lai</span>, <span class="hlFld-ContribAuthor ">Xing-Shu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (4)
                                     , 1523-1526. <a href="https://doi.org/10.1016/j.bmcl.2012.01.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDual%252B%2525CE%2525B22-adrenoceptor%252Bagonists-PDE4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%252Band%252BCOPD%26aulast%3DShan%26aufirst%3DWen-Jun%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1523%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John R.  Cashman</span>, <span class="hlFld-ContribAuthor ">Senait  Ghirmai</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (19)
                                     , 6890-6897. <a href="https://doi.org/10.1016/j.bmc.2009.08.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.08.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.08.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Bserotonin%252Band%252Bnorepinephrine%252Breuptake%252Band%252Binhibition%252Bof%252Bphosphodiesterase%252Bby%252Bmulti-target%252Binhibitors%252Bas%252Bpotential%252Bagents%252Bfor%252Bdepression%26aulast%3DCashman%26aufirst%3DJohn%2BR.%26date%3D2009%26volume%3D17%26issue%3D19%26spage%3D6890%26epage%3D6897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0002.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) EtOC(O)CH-PPH<sub>3</sub>, DCM; (b) H<sub>2</sub>, Pd/C; (c) DiBAL, toluene; (d) [2-(1,3-dioxolan-2-yl)ethyl]triphenylphosphonium bromide; (e) acetone, H<sub>2</sub>SO<sub>4</sub>.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0003.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1-Butenylmagnesium bromide; (b) NBS, DCM; (c) KCN, NaI, DMSO; (d) Raney Ni, H<sub>2</sub>, 1 M NH<sub>3</sub> in MeOH.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0004.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Mg turlings, THF, reflux; (b) <i>cis</i>-1,2,3,6-tetrahydrophthalic anhydride, THF; (c) H<sub>2</sub>NNH<sub>2</sub>, EtOH, reflux; (d) 1,5-dibromopentane, NaH, DMF.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0005.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CsOH·H<sub>2</sub>O, 4 Å sieves, <b>14</b> or <b>15</b>, DMF.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0006.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ethylchloroformate, K<sub>2</sub>CO<sub>3</sub>, THF; (b) LAH, THF.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effect of acute treatment of test compounds on immobility in the forced-swim test in ICR mice: (A) compound <b>14</b> (10 mg/kg, 37 μmol/kg and 30 mg/kg, 112 μmol/kg), (B) compound <b>19</b> (0.3 mg/kg, 1.0 μmol/kg and 3 mg/kg, 10 μmol/kg), and (C) compound <b>21</b> (0.3 mg/kg, 0.5 μmol/kg and 3 mg/kg, 5 μmol/kg). Vehicle (Veh) or test agent was injected ip 30 min prior to the test. <i>n</i> = 9−11; * <i>P</i> < 0.05 vs Veh.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of acute treatment with fluoxetine (20 mg/kg, 65 μmol/kg), compound <b>14</b> (10 mg/kg, 37.4 μmol/kg), and compound <b>15</b> (10 mg/kg, 35.5 μmol/kg) on immobility in the forced-swim test in Balb/c mice. Vehicle or test agent was injected ip 30 min prior to the test. <i>n</i> = 10−11.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/medium/jm-2008-010993_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of subchronic administration of fluoxetine (10 mg/kg, 32.3 μmol/kg), compound <b>14</b> (10 mg/kg, 37.4 μmol/kg), and compound <b>21</b> (1.0 mg/kg, 1.6 μmol/kg) on immobility in the forced-swim test in Balb/c mice. Vehicle or the test agent was injected ip 23, 5, and 1 h prior to the test. <i>n</i> = 10−11; * <i>P</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-6/jm8010993/production/images/large/jm-2008-010993_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8010993&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Warner Schmidt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment</span> <span class="citation_source-journal">Hippocampus</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=239-249&author=J.+L.+Warner+Schmidtauthor=R.+S.+Duman&title=Hippocampal+neurogenesis%3A+opposing+effects+of+stress+and+antidepressant+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%2BSchmidt%26aufirst%3DJ.%2BL.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DHippocampal%2520neurogenesis%253A%2520opposing%2520effects%2520of%2520stress%2520and%2520antidepressant%2520treatment%26jtitle%3DHippocampus%26date%3D2006%26volume%3D16%26spage%3D239%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Preskorn, S. H.; Stanga, C. Y.; Ross, R.</span><span> </span><span class="NLM_article-title">Selective Serotonin Reuptake Inhibitor</span>. In  <span class="citation_source-book">Antidepressants: Past, Present, and Future</span>; <span class="NLM_contrib-group">Preskorn, S. H.; Stanga, C. Y.; Feighner, J. P.; Ross, R.</span>, Eds.; <span class="NLM_publisher-name">Springer Publishing Co.</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">242</span>− <span class="NLM_lpage">264</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=242-264&author=S.+H.+Preskorn&author=C.+Y.+Stanga&author=R.+Rossauthor=S.+H.+Preskorn&author=C.+Y.+Stanga&author=J.+P.+Feighner&author=R.+Ross&title=Antidepressants%3A+Past%2C+Present%2C+and+Future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26atitle%3DSelective%2520Serotonin%2520Reuptake%2520Inhibitor%26btitle%3DAntidepressants%253A%2520Past%252C%2520Present%252C%2520and%2520Future%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26pub%3DSpringer%2520Publishing%2520Co%26date%3D2004%26spage%3D242%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horng, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, B. B.</span><span> </span><span class="NLM_article-title">A new selective inhibitor for uptake of serotonin into synaptosomes or rat brain: 3-(<i>p</i>-trifluoromethylphenoxy)-<i>N</i>-methyl-3-phenylpropylamine (Lilly 110140)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1975</span> <span class="NLM_volume">193</span> <span class="NLM_fpage">804</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=1151730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaE2MXkslajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1975&pages=804-811&author=D.+T.+Wongauthor=F.+P.+Bymasterauthor=J.+S.+Horngauthor=B.+B.+Molloy&title=A+new+selective+inhibitor+for+uptake+of+serotonin+into+synaptosomes+or+rat+brain%3A+3-%28p-trifluoromethylphenoxy%29-N-methyl-3-phenylpropylamine+%28Lilly+110140%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New selective inhibitor for uptake of serotonin into synaptosomes of rat brain.  3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine</span></div><div class="casAuthors">Wong, David T.; Bymaster, Frank P.; Horng, Jong S.; Molloy, Bryan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">804-11</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Lilly 110140 (3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine) [54910-89-3] competitively inhibited the uptake of serotonin (5-HT) [50-67-9], norepinephrine (NE) [51-41-2] and dopamine [51-61-6] into synaptosomes of rat brain with Ki values of 5.5 × 10-8, 9.5 × 10-6 and 1.3 × 10-5 M, resp.  The trifluoromethyl group in the phenoxy ring was most favorable at the para-position and was better than other substituting groups including fluoro, chloro, methyl and methoxy groups.  The N-demethylated (primary amine) and the N,N-dimethylated (tertiary amine) derivs. inhibited the uptake of monoamines with the same effectiveness as Lilly 110140 (a secondary amine).  The uptake of 5-HT into synaptosomes was significantly inhibited 15 min after an intraperitoneal administration of Lilly 110140.  The inhibition persisted for a 24-hr period.  NE uptake in vitro maintained a normal rate during the entire time course.  Lilly 110140 likewise had no effect on the in vitro and in vivo accumulation of 3H-tryptophan in the brain.  The effects of Lilly 110140 and the tricyclic drug, chlorimipramine [303-49-1], were compared.  Although chlorimipramine inhibited the uptake of 5-HT into synaptosomes with same effectiveness as Lilly 110140 in vitro, it reduced the uptake of both 5-HT and NE in vivo.  Chlorimipramine exerted its greatest inhibition on the two uptake processes in the 1st hr and none by the 4th hr.  Unlike the tricyclic drugs, imipramine [50-49-7], chlorimipramine, desipramine [50-47-5] and chlordesipramine [303-48-0].  Lilly 110140 and its primary amine deriv. did not block the in vivo uptake of NE into rat heart.  Thus, Lilly 110140 is a potent and selective inhibitor for uptake of 5-HT into synaptosomes of rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDMsudrbujErVg90H21EOLACvtfcHk0ljMj2zZMxwFsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXkslajs7Y%253D&md5=8a7cd03e92be9f3319eb9d3c6aed498d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DHorng%26aufirst%3DJ.%2BS.%26aulast%3DMolloy%26aufirst%3DB.%2BB.%26atitle%3DA%2520new%2520selective%2520inhibitor%2520for%2520uptake%2520of%2520serotonin%2520into%2520synaptosomes%2520or%2520rat%2520brain%253A%25203-%2528p-trifluoromethylphenoxy%2529-N-methyl-3-phenylpropylamine%2520%2528Lilly%2520110140%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1975%26volume%3D193%26spage%3D804%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, E. A.</span><span> </span><span class="NLM_article-title">Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug (in US): twenty years since its first publication</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">411</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=411-441&author=D.+T.+Wongauthor=F.+P.+Bymasterauthor=E.+A.+Engleman&title=Prozac+%28fluoxetine%2C+Lilly+110140%29%2C+the+first+selective+serotonin+uptake+inhibitor+and+an+antidepressant+drug+%28in+US%29%3A+twenty+years+since+its+first+publication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DEngleman%26aufirst%3DE.%2BA.%26atitle%3DProzac%2520%2528fluoxetine%252C%2520Lilly%2520110140%2529%252C%2520the%2520first%2520selective%2520serotonin%2520uptake%2520inhibitor%2520and%2520an%2520antidepressant%2520drug%2520%2528in%2520US%2529%253A%2520twenty%2520years%2520since%2520its%2520first%2520publication%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D57%26spage%3D411%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span> </span><span class="NLM_article-title">Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">1053</span> <span class="NLM_fpage">54</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1016%2Fj.brainres.2005.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=16040010" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1053&publication_year=2005&pages=54-61&author=K.+Hiranoauthor=T.+Sekiauthor=N.+Sakaiauthor=Y.+Katoauthor=H.+Hashimotoauthor=S.+Uchidaauthor=S.+Yamada&title=Effects+of+continuous+administration+of+paroxetine+on+ligand+binding+site+and+expression+of+serotonin+transporter+protein+in+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DUchida%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26atitle%3DEffects%2520of%2520continuous%2520administration%2520of%2520paroxetine%2520on%2520ligand%2520binding%2520site%2520and%2520expression%2520of%2520serotonin%2520transporter%2520protein%2520in%2520mouse%2520brain%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1053%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span> </span><span class="NLM_article-title">The discovery of fluoxetine hydrochloride (Prozac)</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">764</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1038%2Fnrd1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=16121130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslaqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=764-774&author=D.+T.+Wongauthor=K.+W.+Perryauthor=F.+P.+Bymaster&title=The+discovery+of+fluoxetine+hydrochloride+%28Prozac%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Case History: The Discovery of Fluoxetine Hydrochloride (Prozac)</span></div><div class="casAuthors">Wong, David T.; Perry, Kenneth W.; Bymaster, Frank P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the early 1970s, evidence of the role of serotonin (5-hydroxytryptamine or 5-HT) in depression began to emerge and the hypothesis that enhancing 5-HT neurotransmission would be a viable mechanism to mediate antidepressant response was put forward.  On the basis of this hypothesis, efforts to develop agents that inhibit the uptake of 5-HT from the synaptic cleft were initiated.  These studies led to the discovery and development of the selective serotonin-reuptake inhibitor fluoxetine hydrochloride (Prozac; Eli Lilly), which was approved for the treatment of depression by the US FDA in 1987.  Here, we summarize this research and discuss the many challenges that we encountered during the development of fluoxetine hydrochloride, which has now been widely acknowledged as a breakthrough drug for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsQ0Uof9mDk7Vg90H21EOLACvtfcHk0livq8Wh-TD0yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslaqsL8%253D&md5=9e85885a209317fb10670af0de851978</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1821%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26atitle%3DThe%2520discovery%2520of%2520fluoxetine%2520hydrochloride%2520%2528Prozac%2529%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D764%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haneda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span> </span><span class="NLM_article-title">Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">28</span> <span class="NLM_fpage">6272</span> <span class="NLM_lpage">6280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1523%2FJNEUROSCI.1656-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=18550770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ynsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=6272-6280&author=K.+Kobayashiauthor=Y.+Ikedaauthor=E.+Hanedaauthor=H.+Suzuki&title=Chronic+fluoxetine+bidirectionally+modulates+potentiating+effects+of+serotonin+on+the+hippocampal+mossy+fiber+synaptic+transmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission</span></div><div class="casAuthors">Kobayashi, Katsunori; Ikeda, Yumiko; Haneda, Eisuke; Suzuki, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6272-6280</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Selective serotonin reuptake inhibitors (SSRIs) have been used to treat various psychiatric disorders.  Although the cellular mechanisms underlying amelioration of particular symptoms are mostly unknown, recent studies have shown crit. importance of the dentate gyrus of the hippocampus in behavioral effects of SSRIs in rodents.  Here, we show that serotonin potentiates synaptic transmission between mossy fibers, the sole output of the dentate granule cells, and CA3 pyramidal cells in mouse hippocampal slices.  This potentiation is mediated by activation of 5-HT4 receptors and intracellular cAMP elevation.  A chronic treatment of mice with fluoxetine, a widely used SSRI, bidirectionally modulates the 5-HT-induced potentiation: Fluoxetine enhances the potentiation induced by lower concns. of serotonin, while attenuates that by the higher concn., which represents stabilization of synaptic 5-HT action.  In contrast to the chronic treatment, an acute application of fluoxetine in slices induces a leftward shift in the dose-response curve of the 5-HT-induced potentiation.  Thus, acute and chronic fluoxetine treatments have distinct effects on the serotonergic modulation of the mossy fiber synaptic transmission.  Exposure of mice to novel environments induces increases in locomotor activity and hippocampal extracellular 5-HT levels.  In mice chronically treated with fluoxetine, the novelty-induced hyperactivity is reduced without significant alterations in home cage activity and motor skills.  Our results suggest that the chronic fluoxetine treatment can stabilize the serotonergic modulation of the central synaptic transmission, which may contribute to attenuation of hyperactive behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpraz4UOv7VNrVg90H21EOLACvtfcHk0livq8Wh-TD0yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ynsrY%253D&md5=15f5ce241a0843d3382c747a04fc589b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1656-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1656-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DHaneda%26aufirst%3DE.%26aulast%3DSuzuki%26aufirst%3DH.%26atitle%3DChronic%2520fluoxetine%2520bidirectionally%2520modulates%2520potentiating%2520effects%2520of%2520serotonin%2520on%2520the%2520hippocampal%2520mossy%2520fiber%2520synaptic%2520transmission%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D6272%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">74</span> <span class="NLM_fpage">1257</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=10693959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlChtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=1257-1262&author=Y.+Yeauthor=K.+Jacksonauthor=J.+M.+O%E2%80%99Donnell&title=Effects+of+repeated+antidepressant+treatment+of+type+4A+phosphodiesterase+%28PDE4A%29+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of repeated antidepressant treatment on type 4A phosphodiesterase (PDE4A) in rat brain</span></div><div class="casAuthors">Ye, Ying; Jackson, Keasha; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1257-1262</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In a previous study, an up-regulation of rolipram-sensitive, low-Km, cAMP phosphodiesterase (PDE4) subtype PDE4A in rat cerebral cortex following repeated treatment of desipramine was obsd.  To det. whether this effect is shared by antidepressants from different pharmacol. classes, PDE4A expression was examd. using immunoblot analyses following repeated treatment with the norepinephrine reuptake inhibitor desipramine, the monoamine oxidase inhibitor phenelzine, the atypical antidepressant trazodone, and the serotonin reuptake inhibitor fluoxetine.  Desipramine, phenelzine, and fluoxetine all increased the intensities of the PDE4A bands in hippocampal prepns.; trazodone did not.  In prepns. of cerebral cortex, the intensities of the PDE4A bands were increased following desipramine treatment, not changed following phenelzine or fluoxetine treatment, and decreased following trazodone treatment.  It appears that repeated treatment with antidepressant drugs from different pharmacol. classes produces similar effects on the expressions of PDE4A variants in hippocampus.  This effect is not correlated with the changes in β-adrenergic receptor densities, suggesting these antidepressants may at some point alter intracellular signal transduction pathways in a similar manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKr_pKyZ-rmLVg90H21EOLACvtfcHk0lisCXujZgpjJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlChtro%253D&md5=98053d9a02a290cbd923b0ae13bac3c5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DEffects%2520of%2520repeated%2520antidepressant%2520treatment%2520of%2520type%25204A%2520phosphodiesterase%2520%2528PDE4A%2529%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D1257%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Halene, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">PDE inhibitors in psychiatry—future options for dementia, depression and schizophrenia</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">870</span> <span class="NLM_lpage">878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=870-878&author=T.+B.+Haleneauthor=S.+J.+Siegel&title=PDE+inhibitors+in+psychiatry%E2%80%94future+options+for+dementia%2C+depression+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalene%26aufirst%3DT.%2BB.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DPDE%2520inhibitors%2520in%2520psychiatry%25E2%2580%2594future%2520options%2520for%2520dementia%252C%2520depression%2520and%2520schizophrenia%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D870%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Houslay, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span> </span><span class="NLM_article-title">Keynote review: phosphodiesterase-4 as a therapeutic target</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">1503</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1016%2FS1359-6446%2805%2903622-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=16257373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1503-1519&author=M.+D.+Houslayauthor=P.+Shaferauthor=K.+Y.+Zhang&title=Keynote+review%3A+phosphodiesterase-4+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-4 as a therapeutic target</span></div><div class="casAuthors">Houslay, Miles D.; Schafer, Peter; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1503-1519</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase-4 selective inhibitors have therapeutic potential for treating major diseases such as asthma and COPD, as well as depression, Parkinson's disease and Alzheimer's disease.  CAMP is a key second messenger in all cells.  It is compartmentalized within cells and its levels are controlled, as a result of spatially discrete signaling cassettes controlling its generation, detection and degrdn.  Underpinning compartmentalized cAMP signaling are ∼20 members of the phosphodiesterase-4 (PDE4) family.  The selective inhibition of this family generates profound, functional effects and PDE4 inhibitors are currently under development to provide potential, novel therapeutics for the treatment of inflammatory diseases, such as asthma, chronic obstructive pulmonary disease and psoriasis, as well as treating depression and serving as cognitive enhancers.  Here, we delineate the range of PDE4 isoforms, their role in signaling, their structural biol. and related preclin. and clin. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOabrPCOweLVg90H21EOLACvtfcHk0lisCXujZgpjJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrzL&md5=7c75a76543b75145a44ae8f4a2f3b2ac</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903622-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903622-6%26sid%3Dliteratum%253Aachs%26aulast%3DHouslay%26aufirst%3DM.%2BD.%26aulast%3DShafer%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26atitle%3DKeynote%2520review%253A%2520phosphodiesterase-4%2520as%2520a%2520therapeutic%2520target%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1503%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Diminished noradrenergic activity in the brain down-regulates Type 4 phosphodiesterase in rat cerebral cortex</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">1894</span> <span class="NLM_lpage">1902</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=8780016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK28XisVSku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=1894-1902&author=Y.+Yeauthor=J.+M.+O%E2%80%99Donnell&title=Diminished+noradrenergic+activity+in+the+brain+down-regulates+Type+4+phosphodiesterase+in+rat+cerebral+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex</span></div><div class="casAuthors">Ye, Ying; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1894-902</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">The present study examd. the in vivo regulation of rolipram-sensitive, high-affinity cAMP phosphodiesterase (PDE4) in rat cerebral cortex.  The hydrolysis of cAMP, formed by stimulation of β-adrenergic receptors, was measured in cerebral cortical slices.  Hydrolysis of cAMP formed under these conditions was inhibited by the PDE4-selective inhibitor rolipram but not by selective inhibitors of other PDE families.  Intraventricular infusion of 6-hydroxydopamine (6-OHDA; 200 μg) decreased the rate const. of cAMP hydrolysis and increased the cAMP half-life 17 days, but not 1 or 7 days, following the treatment.  A redn. in norepinephrine (NE) content occurred first; the NE level was reduced to 42, 24, and 6% of control at 1, 7 and 17 days after 6-OHDA infusion, resp.  This was followed by the development of supersensitivity of β-adrenergic receptor-linked adenylyl cyclase, which occurred 7 days after the infusion.  The redn. in PDE4 activity occurred last.  When a higher dose of 6-OHDA (300 μg) was used, the redn. in the rate const. of cAMP hydrolysis occurred by 7 days; at this time NE content was depleted to 6% of control.  Similar to 6-OHDA treatment, continuous blockade of β-adrenergic receptors, produced by chronic propranolol infusion, decreased the rate const. of cAMP hydrolysis.  Therefore, the current results indicate that diminished stimulation of β-adrenergic receptors, either by loss of noradrenergic innervation or by receptor blockade, reduces the activity of PDE4.  This suggests that PDE4 regulation may contribute in the homeostasis of the noradrenergic receptor-effector system in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5RpaxKfxvX7Vg90H21EOLACvtfcHk0ljUeg8Vgx_oeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVSku70%253D&md5=10e4bd31d8d82658542084f89bb64d10</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DDiminished%2520noradrenergic%2520activity%2520in%2520the%2520brain%2520down-regulates%2520Type%25204%2520phosphodiesterase%2520in%2520rat%2520cerebral%2520cortex%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D66%26spage%3D1894%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wachtel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, H. H.</span><span> </span><span class="NLM_article-title">Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_year" style="font-weight: bold;">1986</span> <span class="NLM_volume">25</span> <span class="NLM_fpage">1119</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=1119-1126&author=H.+Wachtelauthor=H.+H.+Schneider&title=Rolipram%2C+a+novel+antidepressant+drug%2C+reverses+the+hypothermia+and+hypokinesia+of+monoamine-depleted+mice+by+an+action+beyond+postsynaptic+monoamine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWachtel%26aufirst%3DH.%26aulast%3DSchneider%26aufirst%3DH.%2BH.%26atitle%3DRolipram%252C%2520a%2520novel%2520antidepressant%2520drug%252C%2520reverses%2520the%2520hypothermia%2520and%2520hypokinesia%2520of%2520monoamine-depleted%2520mice%2520by%2520an%2520action%2520beyond%2520postsynaptic%2520monoamine%2520receptors%26jtitle%3DNeuropharmacology%26date%3D1986%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zhang, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frith, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suvarna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">587</span> <span class="NLM_lpage">595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=587-595&author=H.+T.+Zhangauthor=Y.+Huangauthor=S.+L.+C.+Jinauthor=S.+A.+Frithauthor=N.+Suvarnaauthor=M.+Contiauthor=J.+M.+O%E2%80%99Donnell&title=Antidepressant-like+profile+and+reduced+sensitivity+to+rolipram+in+mice+deficient+in+the+PDE4D+phosphodiesterase+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DS.%2BL.%2BC.%26aulast%3DFrith%26aufirst%3DS.%2BA.%26aulast%3DSuvarna%26aufirst%3DN.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DAntidepressant-like%2520profile%2520and%2520reduced%2520sensitivity%2520to%2520rolipram%2520in%2520mice%2520deficient%2520in%2520the%2520PDE4D%2520phosphodiesterase%2520enzyme%26jtitle%3DNeuropsychopharmacology%26date%3D2002%26volume%3D27%26spage%3D587%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frith, S.</span><span> </span><span class="NLM_article-title">Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">63</span> <span class="NLM_fpage">185</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1999&pages=185-192&author=J.+M.+O%E2%80%99Donnellauthor=S.+Frith&title=Behavioral+effects+of+family-selective+inhibitors+of+cyclic+nucleotide+phosphodiesterases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26aulast%3DFrith%26aufirst%3DS.%26atitle%3DBehavioral%2520effects%2520of%2520family-selective%2520inhibitors%2520of%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D63%26spage%3D185%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokumura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span> </span><span class="NLM_article-title">Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">498</span> <span class="NLM_fpage">135</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1016%2Fj.ejphar.2004.07.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=15363987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFGks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2004&pages=135-142&author=T.+Itohauthor=M.+Tokumuraauthor=K.+Abe&title=Effects+of+rolipram%2C+a+phosphodiesterase+4+inhibitor%2C+in+combination+with+imipramine+on+depressive+behavior%2C+CRE-binding+activity+and+BDNF+level+in+learned+helplessness+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats</span></div><div class="casAuthors">Itoh, Tetsuji; Tokumura, Miwa; Abe, Kohji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">498</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">135-142</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The brain cAMP regulating system and its downstream elements play a pivotal role in the therapeutic effects of antidepressants.  We previously reported the increase in activities of phosphodiesterase 4, a major phosphodiesterase isoenzyme hydrolyzing cAMP, in the frontal cortex and hippocampus of learned helplessness rats, an animal model for depression.  The present study was undertaken to examine the combination of effects of rolipram, a phosphodiesterase 4 inhibitor, with imipramine, a typical tricyclic antidepressant, on depressive behavior in learned helplessness rats.  Concurrently, cAMP-response element (CRE)-binding activity and brain-derived neurotrophic factor (BDNF) levels related to the therapeutic effects of antidepressants were detd.  Repeated administration of imipramine (1.25 - 10 mg/kg, i.p.) or rolipram (1.25 mg/kg, i.p.) reduced the no. of escape failures in learned helplessness rats.  Imipramine could not completely ameliorate the escape behavior to a level similar to that of non-stressed rats even at 10 mg/kg.  However, repeated coadministration of rolipram with imipramine (1.25 and 2.5 mg/kg, resp.) almost completely eliminated the escape failures in learned helplessness rats.  The redn. of CRE-binding activities and BDNF levels in the frontal cortex or hippocampus in learned helplessness rats were ameliorated by treatment with imipramine or rolipram alone.  CRE-binding activities and/or BDNF levels of the frontal cortex and hippocampus were significantly increased by treatment with a combination of rolipram and imipramine compared to those in imipramine-treated rats.  These results indicated that coadministration of phosphodiesterase type 4 inhibitors with antidepressants may be more effective for depression therapy and suggest that elevation of the cAMP signal transduction pathway is involved in the antidepressive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWaiIQbR9XSbVg90H21EOLACvtfcHk0lhL3A_fOOX96g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFGks7c%253D&md5=661db7d2594bf049a4780e7c5addfbd1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.07.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.07.084%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DTokumura%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DEffects%2520of%2520rolipram%252C%2520a%2520phosphodiesterase%25204%2520inhibitor%252C%2520in%2520combination%2520with%2520imipramine%2520on%2520depressive%2520behavior%252C%2520CRE-binding%2520activity%2520and%2520BDNF%2520level%2520in%2520learned%2520helplessness%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D498%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lourenco, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beanlands, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, J. N.</span><span> </span><span class="NLM_article-title">Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (<i>R</i>)-[<sup>11</sup>C]rolipram in rat brain, lung and heart</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">79</span> <span class="NLM_fpage">356</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=356-364&author=C.+M.+Lourencoauthor=M.+Kenkauthor=R.+S.+Beanlandsauthor=J.+N.+DaSilva&title=Increasing+synaptic+noradrenaline%2C+serotonin+and+histamine+enhances+in+vivo+binding+of+phosphodiesterase-4+inhibitor+%28R%29-%5B11C%5Drolipram+in+rat+brain%2C+lung+and+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DIncreasing%2520synaptic%2520noradrenaline%252C%2520serotonin%2520and%2520histamine%2520enhances%2520in%2520vivo%2520binding%2520of%2520phosphodiesterase-4%2520inhibitor%2520%2528R%2529-%255B11C%255Drolipram%2520in%2520rat%2520brain%252C%2520lung%2520and%2520heart%26jtitle%3DLife%2520Sci.%26date%3D2006%26volume%3D79%26spage%3D356%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Van der Mey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzelmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Klink, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Laan, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibaut, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span> </span><span class="NLM_article-title">Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted <i>cis</i>-tetra- and <i>cis</i>-hexahydrophthalazinones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">44</span> <span class="NLM_fpage">2523</span> <span class="NLM_lpage">2535</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010838c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2523-2535&author=M.+Van+der+Meyauthor=A.+Hatzelmannauthor=G.+P.+Van+Klinkauthor=I.+J.+Van+der+Laanauthor=G.+J.+Sterkauthor=U.+Thibautauthor=W.+R.+Ulrichauthor=H.+Timmerman&title=Novel+selective+PDE4+inhibitors.+2.+Synthesis+and+structure-activity+relationships+of+4-aryl-substituted+cis-tetra-+and+cis-hexahydrophthalazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm010838c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010838c%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BMey%26aufirst%3DM.%26aulast%3DHatzelmann%26aufirst%3DA.%26aulast%3DVan%2BKlink%26aufirst%3DG.%2BP.%26aulast%3DVan%2Bder%2BLaan%26aufirst%3DI.%2BJ.%26aulast%3DSterk%26aufirst%3DG.%2BJ.%26aulast%3DThibaut%26aufirst%3DU.%26aulast%3DUlrich%26aufirst%3DW.%2BR.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DNovel%2520selective%2520PDE4%2520inhibitors.%25202.%2520Synthesis%2520and%2520structure-activity%2520relationships%2520of%25204-aryl-substituted%2520cis-tetra-%2520and%2520cis-hexahydrophthalazinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2523%26epage%3D2535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Van der Mey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couwenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzelmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goubitz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span> </span><span class="NLM_article-title">Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration and PDE4 inhibitory activity of <i>cis</i>-tetra- and <i>cis</i>-hexahydrophthalazinones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">45</span> <span class="NLM_fpage">2526</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0110338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2526-2533&author=M.+Van+der+Meyauthor=H.+Bossauthor=D.+Couwenbergauthor=A.+Hatzelmannauthor=G.+J.+Sterkauthor=K.+Goubitzauthor=H.+Schenkauthor=H.+Timmerman&title=Novel+selective+phosphodiesterase+%28PDE4%29+inhibitors.+4.+Resolution%2C+absolute+configuration+and+PDE4+inhibitory+activity+of+cis-tetra-+and+cis-hexahydrophthalazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0110338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0110338%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BMey%26aufirst%3DM.%26aulast%3DBoss%26aufirst%3DH.%26aulast%3DCouwenberg%26aufirst%3DD.%26aulast%3DHatzelmann%26aufirst%3DA.%26aulast%3DSterk%26aufirst%3DG.%2BJ.%26aulast%3DGoubitz%26aufirst%3DK.%26aulast%3DSchenk%26aufirst%3DH.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DNovel%2520selective%2520phosphodiesterase%2520%2528PDE4%2529%2520inhibitors.%25204.%2520Resolution%252C%2520absolute%2520configuration%2520and%2520PDE4%2520inhibitory%2520activity%2520of%2520cis-tetra-%2520and%2520cis-hexahydrophthalazinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2526%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhar, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, J. L.</span><span> </span><span class="NLM_article-title">Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">6401</span> <span class="NLM_lpage">6409</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0401311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6401-6409&author=F.+I.+Carrollauthor=S.+P.+Runyonauthor=P.+Abrahamauthor=H.+Navarroauthor=M.+J.+Kuharauthor=G.+T.+Pollardauthor=J.+L.+Howard&title=Monoamine+transporter+binding%2C+locomotor+activity%2C+and+drug+discrimination+properties+of+3-%284-substituted-phenyl%29tropane-2-carboxylic+acid+methyl+ester+isomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0401311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0401311%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DNavarro%26aufirst%3DH.%26aulast%3DKuhar%26aufirst%3DM.%2BJ.%26aulast%3DPollard%26aufirst%3DG.%2BT.%26aulast%3DHoward%26aufirst%3DJ.%2BL.%26atitle%3DMonoamine%2520transporter%2520binding%252C%2520locomotor%2520activity%252C%2520and%2520drug%2520discrimination%2520properties%2520of%25203-%25284-substituted-phenyl%2529tropane-2-carboxylic%2520acid%2520methyl%2520ester%2520isomers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6401%26epage%3D6409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">289</span> <span class="NLM_fpage">877</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0lg-spHdjvZV1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandrick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashman, J. R.</span><span> </span><span class="NLM_article-title">Synthesis of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">775</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=775-780&author=X.+Fengauthor=K.+Fandrickauthor=R.+Johnsonauthor=A.+Janowskyauthor=J.+R.+Cashman&title=Synthesis+of+3-carbomethoxy-4-%28aryl%29piperidines+and+in+vitro+and+in+vivo+pharmacological+evaluation%3A+identification+of+inhibitors+of+the+human+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DFandrick%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DCashman%26aufirst%3DJ.%2BR.%26atitle%3DSynthesis%2520of%25203-carbomethoxy-4-%2528aryl%2529piperidines%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520evaluation%253A%2520identification%2520of%2520inhibitors%2520of%2520the%2520human%2520dopamine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D775%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lucki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayorga, A. J.</span><span> </span><span class="NLM_article-title">Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">155</span> <span class="NLM_fpage">315</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2001&pages=315-322&author=I.+Luckiauthor=A.+Dalviauthor=A.+J.+Mayorga&title=Sensitivity+to+the+effects+of+pharmacologically+selective+antidepressants+in+different+strains+of+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26aulast%3DDalvi%26aufirst%3DA.%26aulast%3DMayorga%26aufirst%3DA.%2BJ.%26atitle%3DSensitivity%2520to%2520the%2520effects%2520of%2520pharmacologically%2520selective%2520antidepressants%2520in%2520different%2520strains%2520of%2520mice%26jtitle%3DPsychopharmacology%26date%3D2001%26volume%3D155%26spage%3D315%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">The forced swim test as a model for core and component behavioral effects of antidepressant drugs</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">523</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm8010993&amp;key=10.1097%2F00008877-199711000-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=9832966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFGju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=523-532&author=I.+Lucki&title=The+forced+swim+test+as+a+model+for+core+and+component+behavioral+effects+of+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The forced swimming test as a model for core and component behavioral effects of antidepressant drugs</span></div><div class="casAuthors">Lucki, I.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6&7</span>),
    <span class="NLM_cas:pages">523-532</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">A review with 58 refs.  The existence of a no. of classes of antidepressant drugs with diverse pharmacol. effects would lead one to expect that antidepressant drugs acting through different pharmacol. mechanisms should produce different behavioral effects.  Animal behavioral tests used to screen antidepressant drugs do not, however, discriminate between drugs that selectively enhance serotonin or norepinephrine transmission.  Several components of human depression are differently affected by drugs selectively interacting with either serotonin or norepinephrine transmission.  The ideal animal model for detecting antidepressant drug effects should thus be sensitive to all antidepressant drugs and should also display multiple components that are sensitive to specific drug classes.  The revised scoring of the forced swimming test corresponds to a behavioral test for antidepressant drugs that meet these criteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGYjC9W4JE8rVg90H21EOLACvtfcHk0lg-spHdjvZV1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFGju7Y%253D&md5=695a23cc59f05189dcba632ed1cd5124</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2F00008877-199711000-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008877-199711000-00010%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DThe%2520forced%2520swim%2520test%2520as%2520a%2520model%2520for%2520core%2520and%2520component%2520behavioral%2520effects%2520of%2520antidepressant%2520drugs%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1997%26volume%3D8%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span> </span><span class="NLM_article-title">Characterization of a recombinant human dopamine transporter in multiple cell lines</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">274</span> <span class="NLM_fpage">276</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm8010993&amp;key=7616409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8010993&amp;key=1%3ACAS%3A528%3ADyaK2MXntVWlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=276-283&author=A.+J.+Eshlemanauthor=R.+L.+Neveauthor=A.+Janowskyauthor=K.+A.+Neve&title=Characterization+of+a+recombinant+human+dopamine+transporter+in+multiple+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a recombinant human dopamine transporter in multiple cell lines</span></div><div class="casAuthors">Eshleman, Amy J.; Neve, Rachael L.; Janowsky, Aaron; Neve, Kim A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">276-83</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A 3.5-kilobase cDNA encoding the dopamine transporter was isolated from a human substantia nigra cDNA library.  Sequence anal. of the coding region of the transporter identified two nucleotide differences between the cDNA and published human dopamine transporter sequences.  One of the substitutions changed an amino acid conserved among previously cloned dopamine (DA) and norepinephrine transporters, Arg-344, to a methionine.  C6 glioma cells or COS-7 cells transfected with the cDNA (C6-hDAT and Cos7-hDAT cells) accumulated [3H]DA with high affinity (Km = 1.2 and 1.5 μM, resp.), and DA uptake inhibitors had similar potencies in both cell lines.  [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([3H]CFT) bound to membranes prepd. from both cell lines with high affinity (Kd = 2-6 nM), although some expts. with C6-hDAT cell membranes indicated the presence of a second class of binding sites with lower affinity for the radioligand.  Using the high-affinity Kd value for [3H]CFT binding detd. in Cos7-hDAT cells to calc. Ki values, drug affinity for inhibition was highly correlated (r = 0.92) with affinity for inhibition of [3H]DA uptake, although transporter substrates were significantly more potent inhibitors of uptake than of [3H]CFT binding.  The binding of [3H]1-[2-diphenylmethoxy]ethyl-4-(3-phenylpropyl)-piperazine ([3H]GBR-12935) to C6-hDAT cells could not be characterized due to high binding to untransfected C6 cells, but on Cos7-hDAT cells the radioligand labeled a single population of binding sites (Kd = 1 nM).  Inhibition of [3H]GBR-12935 binding by drugs correlated highly with inhibition of either [3H]CFT binding (r = 0.98) or of [3H]DA uptake (r = 0.95).  These results demonstrate that expression of an hDAT cDNA provides a binding site for both [3H]CFT and [3H]GBR-12935, and that the structural features of the human transporter that det. drug affinity for binding are similar to the structural features responsible for inhibition of [3H]DA uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_XowXERwrF7Vg90H21EOLACvtfcHk0lgrPoPlPjlRSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntVWlt7w%253D&md5=8b4986d7fbda5aa74a48693499318d48</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DNeve%26aufirst%3DR.%2BL.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26atitle%3DCharacterization%2520of%2520a%2520recombinant%2520human%2520dopamine%2520transporter%2520in%2520multiple%2520cell%2520lines%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D274%26spage%3D276%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umetsu, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, M.</span><span> </span><span class="NLM_article-title">Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">97</span> <span class="NLM_fpage">6751</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6751-6756&author=G.+Hansenauthor=S.+Jinauthor=D.+T.+Umetsuauthor=M.+Conti&title=Absence+of+muscarinic+cholinergic+airway+responses+in+mice+deficient+in+the+cyclic+nucleotide+phosphodiesterase+PDE4D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DUmetsu%26aufirst%3DD.%2BT.%26aulast%3DConti%26aufirst%3DM.%26atitle%3DAbsence%2520of%2520muscarinic%2520cholinergic%2520airway%2520responses%2520in%2520mice%2520deficient%2520in%2520the%2520cyclic%2520nucleotide%2520phosphodiesterase%2520PDE4D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D6751%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a href="/doi/suppl/10.1021/jm8010993">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82386"></div></div></div></div></div><hr /></hr><p class="last">Analytical data of the target compounds is provided in the <a class="ref internalNav" href="#si1">Supporting Information</a>. This information is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8010993/suppl_file/jm8010993_si_001.pdf">jm8010993_si_001.pdf (35.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8010993&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm8010993%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8010993" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                150KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679943536f18227f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
